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This is the third edition of European cardiovascular disease statistics. The first edition was published 
in 2000 when the European Union (EU) consisted of 15 Member States. After enlargement in 
2004 and then again in 2007, there are now 27 Member States. Much has changed in the last 
seven years, but cardiovascular disease (CVD) remains the main cause of death in the EU.
The European cardiovascular disease statistics was the first publication to bring together all 
the available sources of information about the burden of CVD in Europe, including data on 
death and illness, treatment, the prevalence of behavioural risk factors for CVD (smoking, diet, 
physical inactivity and alcohol consumption), and the prevalence of medical conditions associated 
with CVD (raised cholesterol, raised blood pressure, overweight and obesity, and diabetes). It 
has become an indispensable resource for anybody working on reducing the burden of CVD in 
Europe or in public health generally.
The publication also includes an update of the analysis of economic costs of CVD in Europe, 
first published in the 2005 edition. The figures are staggering: CVD cost the EU just under €192 
billion in 2006, almost €110 billion of which were for health care costs and €82 billion were 
from lost productivity and the cost of informal care. The direct health care costs alone cost each 
resident of the EU €223 per annum.
Coronary heart diseases (CHD) by itself remains the single most common cause of deaths in 
the EU but the 2008 European cardiovascular disease statistics shows a reduction in the crude 
number of CHD deaths when compared with the 2005 edition. This reflects a general trend in 
Western, Northern and Southern European countries, where CHD mortality rates are falling 
steadily. The situation in some Central and Eastern European countries is very different, with 
CHD rates rising dramatically. This gradient is more marked for stroke mortality, where the 
crude number of deaths increased since 2005. Over 200,000 men and nearly 300,000 women 
die of stroke in the EU every year.
The third edition of the European cardiovascular disease statistics is published by the European 
Heart Network. We hope that this important document will be used by policy makers, researchers, 










■ Each year cardiovascular disease (CVD) causes over 4.3 million deaths in Europe and over 
2.0 million deaths in the European Union (EU).
■ CVD causes nearly half of all deaths in Europe (48%) and in the EU (42%).
■ CVD is the main cause of death in women in all countries of Europe and is the main cause 
of death in men in all countries except France, the Netherlands and Spain.
■ CVD is the main cause of the disease burden (illness and death) in Europe (23% of all the 
disease burden) and the second main cause of the disease burden in those EU countries with 
very low child and adult mortality (17%).
■ Death rates from CHD are generally higher in Central and Eastern Europe than in Northern, 
Southern and Western Europe.
■ Death rates from stroke are higher in Central and Eastern Europe than in Northern, Southern 
and Western Europe.
■ CVD mortality, incidence and case fatality are falling in most Northern, Southern and Western 
European Countries but either not falling as fast or rising in Central and Eastern European 
countries.
■ Each year smoking kills over 1.2 million people in Europe (450,000 from CVD) and about 
650,000 people in the EU (185,000 from CVD). The numbers dying in Europe from CVD 
due to smoking rose by 13% between 1990 and 2000.
■ Smoking has been declining in many European countries but the rate of decline is now slowing.
Women are now smoking nearly as much as men in many European countries and girls often 
smoke more than boys.
■ Dietary patterns across Europe - once very different - are now converging.
■ Diets are generally improving in Northern and Western European countries but deteriorating 
in Southern, Central and Eastern European countries.
■ Levels of physical inactivity are high in many European countries.
■ Levels of obesity are increasing across Europe in both adults and children.
■ Over 48 million adults in Europe and 23 million adults in the EU have diabetes and the 
prevalence is increasing.
■ Overall CVD is estimated to cost the EU economy €192 billion a year.
■ Of the total cost of CVD in the EU, around 57% is due to health care costs, 21% due to 






The aim of the publication
This is the third edition of European cardiovascular disease statistics published by the European 
Heart Network. European cardiovascular disease statistics is designed for policy makers, health 
professionals, medical researchers and anyone else with an interest in cardiovascular disease 
(CVD). It provides the most recent statistics related to the incidence, prevalence, causes and 
effects of the disease.
The aim of European cardiovascular disease statistics is to show:
(i) the extent to which CVD is a major health problem in Europe; 
(ii) where, in Europe, this problem is greatest;
(iii) the variability in efforts to treat and prevent CVD across Europe as shown by differences 
in levels of treatment and in levels of risk factors for the disease;
(iv) the economic costs of CVD in the European Union;
(v) trends in CVD mortality, morbidity, treatment and risk factors over time.
European cardiovascular disease statistics is divided into 12 sections. The first two sections on 
mortality and morbidity deal with the burden of CVD in Europe. Next there is a section on 
treatment. Then there are four sections on the main aspects of lifestyle which affect the risk of 
the disease: smoking, diet, physical activity and alcohol consumption. These are followed by four 
sections on the main pathophysiological risk factors for the disease: raised blood pressure, raised 
blood cholesterol, overweight/obesity and diabetes. The final section provides information about 
the economic costs of CVD in the European Union (EU)1. Each section contains a set of tables 
and graphs and a brief description of the data presented. 
In European cardiovascular disease statistics we aim only to describe and not to explain. So, 
although there may be relationships between the various geographical and temporal patterns 
observed, we have made no attempt to draw any conclusions about the strength of these 
relationships or about causality. 
Sources and scope of the data
In compiling the first 11 sections of European cardiovascular disease statistics we have only 
consulted international sources: that is the World Health Organization (WHO), the WHO 
MONICA (monitoring trends and determinants in cardiovascular disease) Project, Eurostat 
(provided by the European Commission), the Food and Agriculture Organization of the United 
Nations, the EU, the European Society of Cardiology etc. In the final section on economic costs, 
we have also consulted national sources. It should be noted that the data presented are extremely 
variable in quality and are only a selection of those available. The original sources need to be 





We also investigated several sources of data from which we have not extracted statistics: either 
because the data provided were similar, but less comprehensive or less recent than those we have 
included, or were not directly relevant to the focus of the publication. 
There are many different definitions of ‘Europe’. We have chosen to use the member states of 
the World Health Organization’s European Region as our definition of ‘Europe’. (An appendix 
provides a list and a map of the European Region and the EU.) The number of European countries 
covered in the tables and graphs varies considerably. We have, where possible, given an overall 
figure for Europe and also for the EU. 
Previous publications
There have been several previous attempts to characterise the burden of CVD in Europe and to 
examine geographical and temporal patterns in the disease and its prevention and treatment. 
Notable in this regard is the 1997 report of a Task Force of the European Society of Cardiology 
on Cardiovascular Mortality and Morbidity Statistics in Europe2 and a report published by the 
European Society of Cardiology entitled Cardiovascular diseases in Europe from which we draw 
data on rates of procedures in Europe3. European cardiovascular disease statistics, complements 
these publications. It is less detailed but more up-to-date than the European Society of Cardiology 
Task Force report and, in contrast to both previous publications, includes data on the prevalence 
of risk factors for CVD and the economic costs of CVD.
This publication is also designed to complement the work of the European Commission on 
monitoring health in the EU. Since the mid-1990s health status reports have been prepared for the 
European Commission on a regular basis. The recent The health status of the European Union: 
narrowing the health gap, was published in 20034. This report- like European cardiovascular 
disease statistics - shows that CVD is the main health problem in the EU. 
1. Because of a paucity of published economic data in many countries, the economic costs section of this publication relates only to 
the EU.
2. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe (1997) The 
burden of cardiovascular diseases mortality in Europe. European Heart Journal 18; 1231-48.
3. European Society of Cardiology (2004) Cardiovascular Diseases in Europe. Nice: ESC.
4. European Commission (2003) The health status of the European Union:  narrowing the health gap. Luxembourg: Office for Official 







Diseases of the heart and circulatory system (cardiovascular disease or CVD) are the main cause 
of death in Europe: accounting for over 4.30 million deaths each year1. Nearly half (48%) of all 
deaths are from CVD (54% of deaths in women and 43% of deaths in men). The main forms of 
CVD are coronary heart disease (CHD) and stroke. Just under half of all deaths from CVD are 
from CHD and nearly a third are from stroke (Table 1.1, Figures 1.1a and 1.1b). 
CVD is also the main cause of death in the European Union (EU) accounting for over 2.0 million 
deaths each year. Nearly half (42%)2 of all deaths in the EU (45% deaths in women and 38% 
deaths in men) are from CVD - slightly less than for Europe as a whole. Over a third of deaths 
from CVD are from CHD and just over a quarter are from stroke (Table 1.1, Figures 1.1c and 
1.1d). 
CHD by itself is the single most common cause of death in Europe: accounting for 1.92 million 
deaths in Europe each year. Over one in five women (22%) and over one in five men (21%) die 
from the disease (Table 1.1).
CHD by itself is also the single most common cause of death in the EU: accounting for over 
741,000 deaths in the EU each year. Around one in six men (16%) and over one in seven women 
(15%) die from the disease (Table 1.1).
Stroke by itself is the second single most common cause of death in Europe: accounting for 1.24 
million deaths in Europe each year. Over one in six women (17%) and one in ten men (11%) 
die from the disease (Table 1.1)
Stroke by itself is also the second single most common cause of death in the EU: accounting for 
just over 508,000 deaths in the EU each year. Around one in ten men (9%) and one in eight 
women (12%) die from the disease (Table 1.1).
CVD is the main cause of death for women in all 48 countries of Europe for which we have 
mortality data and it is the main cause of death for men in all these countries except France, the 
Netherlands and Spain3. CVD causes more than 50% of deaths in women in 25 countries. These 
countries are mostly in Central and Eastern Europe but they also include some Southern and 
Western European countries such as Greece. CVD causes more than 50% of deaths in men in eight 
countries: Armenia, Azerbaijan, Bulgaria, Georgia, FYR Macedonia, Serbia and Montenegro, 
Romania, and Ukraine (Table 1.1).
CVD is the main cause of death for women in all 27 countries of the EU and it is the main cause 
of death for men in all these countries except France, the Netherlands and Spain3. For men living 
in EU countries CVD causes between 62% (Bulgaria) and 26% of deaths (France)3 and for women 





Deaths before the age of 75 
CVD is the main cause of deaths before the age of 75 in Europe: accounting for over 1.81 million 
deaths each year. 43% of deaths before the age of 75 in women and 38% of deaths before the age 
of 75 in men are from CVD. One in four of all men (25%) and one in six of all women (16%) 
die from CVD before the age of 75 (Tables 1.1 and 1.2, Figures 1.2a and 1.2b). 
CVD is the second main cause of death before the age of 75 in the EU: accounting for over 
576,000 deaths. CVD causes 30% of deaths but cancer causes 36% of deaths. 31% of deaths 
before the age of 75 in men and 29% of deaths before the age of 75 in women are from CVD. 
One in six of all men (16%) and one in 12 of all women (8%) die from CVD before the age of 
75 (Tables 1.1 and 1.2, Figures 1.2c and 1.2d). 
CHD by itself is the single most common cause of death before the age of 75 in Europe: accounting 
for over 900,000 deaths. 20% of deaths before the age of 75 in men and 19% of deaths before 
the age of 75 in women are from CHD (Table 1.2, Figures 1.2a and 1.2b).
CHD by itself is the single most common cause of death before the age of 75 in the EU: accounting 
for over 250,000 deaths. In the EU CHD causes 15% of deaths before the age of 75 in men – more 
than the most common form of cancer in men - lung cancer - which causes 11% of deaths. CHD 
causes 10% of deaths before the age of 75 in women - more that the most common form of cancer 
in women - breast cancer - which causes 8% of deaths (Table 1.2, Figures 1.2c and 1.2d).
Stroke accounts for almost 500,000 deaths among those aged 75 and under in Europe. Of all 
deaths in Europe among those aged under 75 almost one in ten men (9%) and one in seven 
women (14%) die from stroke. 
Stroke accounts for just over 130,000 deaths among those aged 75 and under in the EU. Of the 
deaths in the EU among those aged under 75 6% of men and 8% of women die from stroke.
CVD is the main cause of death before the age of 75 for men in 28 of the 48 countries of Europe 
for which we have mortality data and for women in 23 countries. The countries where CVD is the 
main cause of death before the age of 75 are generally Central and Eastern European countries but, 
for men in particular, they also include Northern, Southern and Western countries. CVD causes 
between 61% (Georgia) and 18% (France)3 of deaths before the age of 75 in men, and between 
64% (Georgia) and 16% (France)3 of deaths before the age of 75 in women (Table 1.2).
CVD is the main cause of death before the age of 75 for men in 12 countries out of 27 in the EU 
(Bulgaria, Cyprus, Czech Republic, Estonia, Finland, Hungary, Latvia, Lithuania, Malta, Poland, 
Romania and Slovakia). For women it is the main cause in seven countries: Bulgaria, Estonia, 
Hungary, Latvia, Lithuania, Romania and Slovakia (Table 1.2).
Deaths before the age of 65 
CVD is the main cause of death before the age of 65 in Europe: accounting for over 803,000 
deaths each year. 31% of deaths before the age of 65 in men and 29% of deaths before the age 
of 65 in women are from CVD. One in eight of all men (12%) and one in 20 of all women (5%) 
die from CVD before the age of 65 (Tables 1.1 and 1.3, Figures 1.3a and 1.3b).
CVD is the second main cause of death before the age of 65 in the EU: accounting for just under 





before the age of 65 in men and 19% of deaths before the age of 65 in women are from CVD. 
7% of all men and 3% of all women die from CVD before the age of 65 (Tables 1.1 and 1.3, 
Figures 1.3c and 1.3d).
CHD by itself is the single most common cause of death before the age of 65 in Europe: accounting 
for just under 401,000 deaths. 17% of deaths before the age of 65 in men and 12% of deaths 
before the age of 65 in women are from CHD (Table 1.3, Figures 1.3a and 1.3b).
CHD by itself is the single most common cause of death before the age of 65 in the EU: accounting 
for just over 104,000 deaths. In the EU, CHD causes 13% of deaths before the age of 65 in 
men - more than the most common form of cancer in men - lung cancer - which causes 10% of 
deaths. CHD causes 6% of deaths before the age of 65 in women - less than the most common 
form of cancer in women - breast cancer - which causes 11% of deaths (Table 1.3, Figures 1.3c 
and 1.3d).
Stroke accounts for more than 190,000 deaths among those aged 65 and under in Europe. Of 
all deaths in Europe among those aged under 65 6% of men and one in eleven women (9%) die 
from stroke. 
Stroke accounts for just under 48,000 deaths among those aged 65 and under in the EU. Of all 
deaths in the EU among those aged under 65 5% of men and 6% of women die from stroke.
CVD is the main cause of death before the age of 65 for men in 26 of the 48 countries of Europe 
for which we have mortality data and for women in 17 countries. In women, the countries 
where CVD is the main cause of death before the age of 65 are all Central and Eastern European 
countries. CVD causes between 50% (Georgia) and 15% (France)3 of deaths before the age of 
65 in men, and between 46% (Georgia) and 11% (France)3 of deaths before the age of 65 in 
women (Table 1.3).
CVD is the main cause of death before the age of 65 for men in 11 countries in the EU (Bulgaria, 
Cyprus, Estonia, Finland, Hungary, Latvia, Lithuania, Malta, Poland, Romania and Slovakia). For 
women it is the main cause of death before the age of 65 in three countries in the EU: Bulgaria, 
Latvia and Romania (Table 1.3).
Death rates
Death rates from CHD are generally higher in Central and Eastern Europe than in Northern, 
Southern and Western Europe. For example the death rate for men aged under 65 living in Ukraine 
is fourteen times higher than in France3 and for women it is twenty-five times higher. Western 
European countries generally have higher rates than Southern European countries. For example 
the death rate for men aged under 65 living in Ireland is 1.6 times higher than in Italy and for 
women it is 1.8 times higher (Table 1.4, Figures 1.4a and 1.4b).
Death rates from stroke are higher in Central and Eastern Europe than in Northern, Southern 
and Western Europe. For example the death rate in men aged under 65 living in the Russian 
Federation is twenty times higher than in Switzerland and for women of the same age it is fifteen 
times higher (Table 1.5, Figures 1.5a and 1.5b).
Over the past 30 years death rates from CHD have been falling rapidly in most Northern and 





For example death rates for men aged under 65 living in Finland and the United Kingdom fell by 
37% and 42% respectively between 1994 and 2004, but rose by 57% for men of the same age 
living in Albania and by 19% for men living in the Ukraine. For women aged under 65 living 
in Finland and the United Kingdom death rates fell by 35% and 49% respectively, but rose by 
46% for women living in Albania and by 19% for women living in Ukraine (Table 1.4, Figures 
1.4c and 1.4d).
Death rates from stroke are falling rapidly in most European countries with some exceptions. 
For example death rates for men aged under 65 living in Germany and UK fell by 43% and 28% 
respectively between 1994 and 2004. For women aged 65 and under living in Germany and UK 
death rates fell by 37% and 28% respectively but rose by 15% for women living in Albania 
(Table 1.5, Figure 1.5c and 1.5d).
A recent publication by the Institute des Sciences de la Sante, describes changes in CHD mortality 
in under 75s in the EU over a decade, between 1990/91 and 2000/02. Age-standardized death 
rates fell in all countries, but not equally across the EU. Death rates almost halved in four 
countries - the Czech Republic, the UK, Ireland and Finland. Elsewhere rates fell by about one 
fifth to one-third, the only exceptions being Latvia (men) and Poland (women) where there were 
improvements of just over 10%4.
The WHO MONICA Project measured trends in CHD mortality between the early 1980s and 
1990s, in 37 populations worldwide, including 29 populations in Europe. Results showed that 
around two-thirds of the decline in CHD mortality during this period was due to a decline in 
CHD incidence rates and the remaining one-third was due to improvements in survival because 
of better treatments. This highlights the importance of improvements in cardiovascular risk 
factors such as smoking5.
This conclusion was also found in a recent study looking at the decline in CHD mortality over a 
20-year period in the UK. The authors found that between 1981 and 2000 in England and Wales, 
58% of the decline was attributable to reductions in major risk factors, principally smoking, 
whereas treatment of individuals, including secondary prevention, explained the remaining 42% 
of the mortality decline6.
Years of life lost due to an early death
CVD is not only the main cause of death in Europe and the EU but is also the main cause of 
years lost due to an early death.
The WHO Global Burden of Disease Study found that in 1990 on average 31% of years of life 
lost were due to CVD in ‘Established Market Economies’ (mostly Northern, Southern and Western 
countries in Europe and all the member states of the EU - 15). This was more than any other 
cause. On average 16% of years of life lost were due to CHD in Established Market Economies, 
so by itself CHD was the most important cause of years of life lost in these countries7.
In Central and Eastern European countries 35% of years of life lost were due to CVD - again 





1. When we state, in this section, that CVD is the main cause of death we are comparing “Diseases of the circulatory system” (Chapter 
IX 10th Revision) of the International Classification of Diseases, with other chapters (e.g. Chapter II “Neoplasms”). When we state 
that CHD is the most common cause of death we are comparing CHD ( Chapter IX, I20-I25, 10th Revision) with all diseases within 
all chapters (e.g. with lung cancer, Chapter II, C33-C34, 10th Revision).
2. This figure and similar figures in the text are calculated from the tables rather than the graphs. Figures in the text may not seem to 
correspond exactly to figures in graphs because of rounding.
3. Data from the WHO MONICA project suggest that official mortality statistics in France under-report deaths from CVD compared 
to other countries. MONICA data from the French populations included in the MONICA Project (Lille, Strasbourg and Toulouse) 
show an underestimate of CHD deaths of over 75%. (See WHO Monica Project (2003) MONICA Monograph and Multimedia 
Sourcebook: World’s largest study of heart disease stroke, risk factors and population trends 1979-2002. Edited by Hugh Tunstall-
Pedoe for the WHO MONICA Project. WHO: Geneva). Table 1.1 also highlights that doctors in France have a much higher rate 
of reporting deaths from “all other causes”. Together these suggest that the true numbers and proportions of deaths from CVD and 
CHD in France are likely to be higher than those reported in Table and Figures 1.1.
4. Newey C, Nolte E, Mckee M and Mossialos E (2004) Avoidable mortality in the Enlarged European Union. ISS Statistics 2. 
Brussels:ISS.
5. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P, for the WHO MONICA Project (1999) 
Contribution of trends in survival and coronary event rates to changes in coronary heart disease mortality: 10 year results from 
37 WHO MONICA Project populations. Monitoring trends and determinants in cardiovascular disease. The Lancet; 353: 1547-
1557.
6. Unal B, Critchley J and Capewell S (2004) Explaining the decline in coronary heart disease mortality in England and Wales between 
1981 and 2000. Circulation; 109:1101-1107.























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.1c Deaths by cause, men, latest available year, 
EU






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.2a Deaths under 75 by cause, men, latest available 
year, Europe









































Figure 1.2c Deaths under 75 by cause, men, latest available 
year, EU






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1.3a Deaths under 65 by cause, men, latest available 
year, Europe









































Figure 1.3c Deaths under 65 by cause, men, latest available 
year, EU




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   





















































   



























































   



































































































































































































   
















































































































   







































































   



















































































































































































































































































































































































   






































   


















































































































































































   
















































































































































































































   



















































































































































































































































   























































































































































































































































   







































































































































   


































































   

































































   






































































   



























































   























































































































































































   








































































   

























































































   



































































   











































































































































































   











































































































































































































































































   








































































































































































Figure 1.4a Age-standardized death rates from CHD, men 








Figure 1.4b Age-standardized death rates from CHD, 












Figure 1.4c Death rates from CHD, men aged under 65, 
1972 to 2005, selected countries
Figure 1.4d Death rates from CHD, women aged under 65, 














































































































































































































































































































































   






















































   



























































   


































































































































































































   





















































































































   







































































   



























































































































































































































































































































































































   

































































   




















































































































































































   





































































































































































































   



































































































































































































































































   






























































































































































































































































   


































































































































   
































































   































































   






































































   







































































   






















































































































































































   








































































   































































































































   



































































   













































































































































































   










































































































































































































































































   

















































































































































































   






















































   



























































   






















































































































































































   











































































































   







































































   








































































































































































































































































































































































   
















































   

































































































































































   






























































































































































































   













































































































































































































































   
























































































































































































































































   


























































































































   
















































   














































   






































































   






































































   























































































































































































   




































































   











































































































   


















































   



































































































































































   



































































































































































































































































   





































































































































































Figure 1.5a Age-standardized death rates from stroke, men 
aged 0 to 64, latest available year
Figure 1.5b Age-standardized death rates from stroke, 



















Figure 1.5c Death rates from stroke, men aged under 65, 
1972 to 2005, selected countries
Figure 1.5d Death rates from stroke, women aged under 































































































































































































Comparable data on morbidity from CVD are more difficult to collect than mortality data, 
since there are many different measures of morbidity (e.g. prevalence, incidence, DALYs, years 
of healthy life lost etc.). At present, there is no routinely updated source of Europe-wide CVD 
morbidity data1.
The WHO MONICA (monitoring trends and determinants in cardiovascular disease) project2 
examined the incidence of major coronary events in 37 different populations in 21 countries 
(including 29 populations in 16 European countries). Although the data from the study are now 
more than 10 years old, it still represents the most recent Europe-wide comparable dataset on 
CVD morbidity. These populations are not necessarily representative of the countries in which 
they are located. Nevertheless the project has shown that the incidence of coronary events (a 
definite or likely myocardial infarction - heart attack) is higher in MONICA project populations 
in Northern, Central and Eastern Europe than in Southern and Western Europe. For example 
the coronary event rate for men aged 35 to 64 living in Warsaw (Poland) is nearly three times 
higher than it is in Catalonia (Spain); for women it is four times higher. The highest coronary 
event rates at the end of the project were found in Glasgow (United Kingdom) in both men and 
women. The geographical pattern in coronary event rates is similar to the pattern in death rates 
(Table 2.1).
The results of the MONICA project also show that incidence of coronary events is falling rapidly 
in most of the MONICA project populations in Northern and Western Europe but is not falling 
as fast in the populations in Southern, Central and Eastern Europe and in some cases is rising 
in these populations. For example incidence rates for men aged 35 to 64 living in North Karelia 
(Finland) fell by 6.5% per year over the study period (1983 to 1996) but rose by 1.2% for men 
of the same age living in Kaunas (Lithuania). For women aged 35 to 64 living in North Karelia 
the incidence rate fell by 5.1% per year but rose by 2.7% per year for women living in Kaunas. 
The geographical pattern in trends in incidence rates is similar to the geographical pattern in 
trends in death rates (Table 2.1)3.
Case fatality
The MONICA project also investigated patterns and trends in case fatality. Case fatality is defined 
by the MONICA project as dying within 28 days of a coronary event. Case fatality rates are 
affected by many factors including the accuracy of diagnosis, the severity of the disease and the 
impact of treatment. The MONICA project shows that case fatality from CHD is higher in many 
populations in Central and Eastern Europe than in most populations in Northern, Southern and 
Western Europe. For example case fatality for men aged 35 to 64 living in Moscow (Russia) is 
50% higher than in Belfast (United Kingdom) or in Catalonia (Spain) (Table 2.1).
The results of the MONICA project also show that case fatality is falling in most of the MONICA 
project populations in Southern, Northern and Western Europe but is not falling as fast in the 





example case fatality for women aged 35 to 64 living in Toulouse (France) fell by 3.6% per year 
over the study period; over the same period the case fatality rate for women in Moscow increased 
by an average of 1.5% per year (Table 2.1).
The MONICA project was partly established to investigate how much of reported declines in 
CHD mortality are attributable to improvements in case fatality and how much to declines in 
incidence. The project concludes that the ‘contribution to changing CHD mortality varied, but 
in populations in which mortality decreased, coronary-event rates contributed two thirds and 
case fatality one third’2.
Patterns of CHD incidence and case fatality across Europe may have changed since the mid 
1990s. Furthermore, the definition of myocardial infarction (heart attack) has changed following 
the introduction of troponin estimations which have increased the ability to detect myocardial 
infarction.
Years of life lost in disability and disability-adjusted 
life years lost
In 2002 the WHO Burden of Disease project synthesized data from WHO member states to make 
an estimate of the morbidity caused by different diseases4. The main measure of the burden of 
disease was the DALY (Disability Adjusted Life Year) – an aggregate of years of life lost due to 
premature death and years of healthy life lost due to disability.
In developed European countries, 17% of all DALYs lost are due to CVD – after neuropsychiatric 
disorders this represents the largest single cause. In less developed European nations, the proportion 
of DALYs lost due to CVD exceeds that of neuropsychiatric disorders. In the EU, over 12 million 
DALYs (19% of total) are lost each year to CVD. In Europe, over 34 million DALYs (23% of 
total) are lost each year to CVD (Table 2.2 and Figures 2.2a and 2.2b).
The highest morbidity rates for CVD appear in Eastern Europe and in the former Soviet countries. 
The age-standardised rates of DALYs lost for CHD in Ukraine, Russia and Belarus are at least 
three times higher than rates in Spain, France and Italy. The situation is similar for stroke, where 
the rate of DALYs lost in Russia is nearly 1,800 per 100,000, compared to only 360 per 100,000 
in the UK (Table 2.3 and Figures 2.3a and 2.3b).
1. The EUROCISS project (Cardiovascular Indicators Surveillance Set), which is co-funded by the European Commission, and 
working in conjunction with EU member states, has developed a set of standard indicators to improve the comparability, data 
quality and subsequent monitoring of CVD in the EU  (see www.cuore.iss.it/eurociss/en/eurociss.htm) 
2. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P, for the WHO MONICA project (1999) 
Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10 year results from 37 
MONICA project populations. Lancet 353; 1547-57.
3. For more details see WHO Monica project (2003) MONICA Monograph and Multimedia Sourcebook: World’s largest study 
of heart disease stroke, risk factors and population trends 1979-2002. Edited by Hugh Tunstall-Pedoe for the WHO MONICA 
project. WHO: Geneva.





Table 2.1 Coronary event rates, coronary case fatality, annual change 
in coronary event rates and annual change in coronary case 
fatality by sex, adults aged 35 to 64, latest available year, 
MONICA European Project populations
MONICA population MONICA  Survey Coronary event Coronary case Annual change in Annual change in 
 population  years rate fatality coronary event coronary case 
 code   within 28 days rate fatality
   Events per  
   100,000 % % %
MEN
Belgium-Charleroi BEL-CHA 1983/92 487 50 0.3 -1.8
Belgium-Ghent BEL-GHE 1983/92 346 47 -3.2 -1.6
Czech Republic CZE-CZE 1984/93 515 53 -0.4 0.7
Denmark-Glostrup DEN-GLO 1982/91 517 53 -4.2 1.5
Finland-Kuopio Province FIN-KUO 1983/92 718 46 -6.0 1.0
Finland-North Karelia FIN-NKA 1983/92 835 48 -6.5 -0.5
Finland-Turku/Loimaa FIN-TUL 1983/92 549 49 -4.2 -0.2
France-Lille FRA-LIL 1985/94 298 59 -1.1 -0.3
France-Strasbourg FRA-STR 1985/93 292 49 -3.9 -1.7
France-Toulouse FRA-TOU 1985/93 233 40 -2.1 -3.8
Germany-Augsburg GER-AUG 1985/94 286 55 -3.2 1.3
Germany-Bremen GER-BRE 1985/92 361 50 -3.4 -0.9
Germany-East Germany GER-EGE 1985/93 370 50 -0.5 1.7
Iceland ICE-ICE 1981/94 486 37 -4.7 -2.1
Italy-Area Brianza ITA-BRI 1985/94 279 41 -2.3 -0.8
Italy-Friuli ITA-FRI 1984/93 253 45 -0.9 -2.0
Lithuania-Kaunas LTU-KAU 1983/92 498 55 1.2 1.0
Poland-Tarnobrzeg Vovoidship POL-TAR 1984/93 461 83 1.1 1.2
Poland-Warsaw POL-WAR 1984/94 586 60 0.8 -0.4
Russia-Moscow (control) RUS-MOC 1985/93 477 61 -1.0 3.0
Russia-Novosibirsk (control) RUS-NOC 1984/92 464 60 0.9 -0.1
Spain-Catalonia SPA-CAT 1985/94 210 37 1.8 -1.7
Sweden-Gothenburg SWE-GOT 1984/94 363 44 -4.2 0.3
Sweden-Northern Sweden SWE-NSW 1985/95 509 36 -5.1 -2.9
Switzerland-Ticino SWI-TIC 1985/93 290 34 -2.6 -4.2
Switzerland-Vaud/Fribourg SWI-VAF 1985/93 231 38 -3.6 -3.0
United Kingdom-Belfast UNK-BEL 1983/93 695 41 -4.6 -1.5
United Kingdom-Glasgow UNK-GLA 1985/94 777 48 -1.4 -1.3
Yugoslavia-Novi Sad YUG-NOS 1984/95 422 52 0.4 -0.4
WOMEN
Belgium-Charleroi BEL-CHA 1983/92 118 59 1.1 -1.8
Belgium-Ghent BEL-GHE 1983/92 77 58 -3.0 -1.8
Czech Republic CZE-CZE 1984/93 101 54 2.1 -1.2
Denmark-Glostrup DEN-GLO 1982/91 140 58 -2.5 2.5
Finland-Kuopio Province FIN-KUO 1983/92 124 39 -4.5 1.0
Finland-North Karelia FIN-NKA 1983/92 145 41 -5.1 -0.2
Finland-Turku/Loimaa FIN-TUL 1983/92 94 49 -4.5 -1.9
France-Lille FRA-LIL 1985/94 64 70 -1.6 0.8
France-Strasbourg FRA-STR 1985/93 64 57 -6.6 -2.3
France-Toulouse FRA-TOU 1985/93 36 60 -1.7 -3.6
Germany-Augsburg GER-AUG 1985/94 63 65 0.9 -0.4
Germany-Bremen GER-BRE 1985/92 81 52 0.7 -2.9
Germany-East Germany GER-EGE 1985/93 78 63 2.5 -2.2
Iceland ICE-ICE 1981/94 99 34 -3.7 -1.0
Italy-Area Brianza ITA-BRI 1985/94 42 53 -3.5 -4.8
Italy-Friuli ITA-FRI 1984/93 47 50 -0.8 -2.0
Lithuania-Kaunas LTU-KAU 1983/92 80 54 2.7 -1.2
Poland-Tarnobrzeg Vovoidship POL-TAR 1984/93 110 88 -0.1 -0.7
Poland-Warsaw POL-WAR 1984/94 153 59 1.0 -2.1
Russia-Moscow (control) RUS-MOC 1985/93 92 60 -6.7 1.5
Russia-Novosibirsk (control) RUS-NOC 1984/92 111 67 2.3 0.3
Spain-Catalonia SPA-CAT 1985/94 35 46 2.0 1.5
Sweden-Gothenburg SWE-GOT 1984/94 84 45 -3.7 1.2
Sweden-Northern Sweden SWE-NSW 1985/95 119 34 -2.4 0.4
United Kingdom-Belfast UNK-BEL 1983/93 188 42 -2.4 -1.7
United Kingdom-Glasgow UNK-GLA 1985/94 265 46 0.2 -2.1
Yugoslavia-Novi Sad YUG-NOS 1984/95 101 50 2.8 0.5
Notes: Age-standardized rates - see source for details.
Source: Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P, for the WHO MONICA Project (1999). Contribution of trends in 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.2a Disability-adjusted life years lost by cause, 
2002, Europe


































Table 2.3 Age-standardized DALYs rate for CHD, stroke 
and other CVD by country, 2002, Europe
 Age-standardized DALYs lost per 100,000
 CHD Stroke Other CVD
Albania 1,107 1,006 884
Andorra * 313 271 266
Armenia 1,750 855 413
Austria 579 349 431
Azerbaijan 2,316 767 795
Belarus 2,497 1,239 543
Belgium 512 356 321
Bosnia and Herzegovina * 925 1,107 1,514
Bulgaria 1,344 1,188 1,485
Croatia 973 989 570
Cyprus 638 289 832
Czech Republic 945 629 452
Denmark 478 401 359
Estonia 1,449 819 714
Finland 687 411 299
France 259 271 360
Georgia 2,103 1,552 504
Germany 574 338 481
Greece 620 592 454
Hungary 1,137 731 654
Iceland 470 278 176
Ireland 671 361 359
Israel 370 214 284
Italy 409 335 363
Kazakhstan 2,452 1,469 1,326
Kyrgyzstan 1,885 1,939 687
Latvia 1,606 1,102 803
Lithuania 1,444 620 608
Luxembourg 403 420 397
Macedonia, TFYR 838 1,066 1,043
Malta 709 365 235
Moldova 1,922 1,327 312
Monaco * 247 250 322
Netherlands 460 329 411
Norway 503 309 267
Poland 949 598 657
Portugal 431 836 301
Romania 1,176 1,162 793
Russian Federation 2,630 1,747 1,174
San Marino 431 282 689
Serbia and Montenegro 1,087 1,102 1,149
Slovakia 1,037 387 795
Slovenia 552 524 492
Spain 368 294 274
Sweden 506 300 284
Switzerland 380 200 318
Tajikistan 1,886 571 1,912
Turkey 1,332 1,132 790
Turkmenistan 2,860 620 2,825
Ukraine 2,539 1,207 633
United Kingdom 657 359 298
Uzbekistan 1,907 975 1,159
Notes:  The estimates should be interpreted as the best estimates of WHO, rather than the official viewpoint of member states. For 
details on age-standardization, see source.
 * accuracy of estimates is lower than for other countries, due to data quality.





Figure 2.3a Age-standardized DALYs rate for CHD, 2002, 
Europe
























Rates of admissions (or more technically discharges) for CVD vary considerably across Europe. 
For example, the hospital admission rate is over four times higher in Belarus than in Portugal. In 
general, higher admission rates are found in Eastern European and Scandanavian countries. Similar 
geographical trends are seen for CHD and, to a lesser extent, stroke (Tables 3.1, 3.2 and 3.3).
Temporal trends in admission rates reflect patterns in mortality and morbidity discussed in previous 
chapters. Since 1995 (where comparable data across Europe are more readily available) the rates 
in some Eastern European and former Soviet countries have increased rapidly, whereas the rates 
in Western European countries have been relatively stable. In particular, the rates in Scandanavia 
have not increased substantially since 1995, suggesting that rates in Eastern European countries 
may soon overtake these rates. Similar temporal trends are apparent for CHD and stroke (Tables 
3.1, 3.2 and 3.3).
Coronary revascularisation and other procedures for 
CVD
Rates of coronary revascularisation and other procedures for CVD vary widely across Europe. 
In general, Central and Eastern European countries have lower rates than Northern, Southern 
and Western countries. Within Northern, Southern and Western European countries there is no 
consistent geographical pattern but some countries, for example France, have high rates for all 
procedures (Table 3.4).
The differences in procedure rates are difficult to account for. For example, coronary artery 
bypass graft rates are much higher in Finland, Israel and Sweden than would be expected from 
comparisons of standardised mortality ratios for CHD. Similarly, rates are much lower than 
would be expected in Latvia, Estonia and Romania. Analysis of rates for percutaneous coronary 
interventions shows other anomalies: Germany, Israel and France have rates higher than expected 
whilst rates in Finland, Ireland and the UK are lower than would be expected, and rates in the 
Balkan states and Romania are much lower than expected (Figures 3.4a and 3.4b).
While rates of revascularisation vary widely across Europe, all countries have seen rates increase 
significantly since the 1990s. For example, since 1990 rates of PCI have increased twenty-fold in 
Hungary, fifteen-fold in Italy and twelve-fold in Finland. Most recently, the biggest increase in 
rates of PCI have been in Eastern European countries and Baltic States, including, for example, 
a twelve fold increase in Latvia between 1995 and 2000 (Table 3.5 and Figure 3.5).
Drugs
The European Society of Cardiology EUROASPIRE project has collected, among other data, 
information on drug prescriptions for cardiovascular conditions in hospitals in a number of 
European countries. While not necessarily representative of national prescribing patterns these 





showed that the use of drugs for secondary prevention in CHD patients varied considerably across 
survey populations, except in the case of anti-platelt drugs where over 80% of patients took this 
form of drug (mostly aspirin) in the countries studied. The use of beta blockers varied two-fold 
(from 44% in Hull and London, UK to 88% in Lille, France), as did the use of lipid-lowering 
drugs. The use of ACE inhibitors varied three-fold (from 19% in Malmo, Sweden to 69% in 
Ljubljana, Slovenia) (Table 3.6).
Recently data on the eight countries that have taken part in all three EUROASPIRE surveys to 
date have been released. Data from the most recent survey (2005/06) suggest that there is little 
variation in prescribing rates, particularly for anti-platelets and lipid-lowering drugs where all 
eight survey populations showed rates of at least 80%. There is some variation in the rate of 
prescribing beta blockers: 74% of patients in France compared to 96% of patients in Finland 
were prescribed these drugs (Table 3.6).
Since 1995/96 the prescription of lipid-lowering drugs has massively increased in Europe. The 
prescription rate for these drugs has at least doubled in all eight EUROASPIRE populations 
for which data are available. In Italy, the rate has more than tripled, increasing from 25% in 
1995/96 to 91% in 2005/06. There has also been a large increase in the prescription of ACE 
inhibitors, although in general the prescription rates for these drugs are lower than for lipid-
lowering drugs1.
This general increase in the use of drugs for secondary prevention noted by EUROASPIRE, has 
also been found in more representative studies carried out at a national level. For example, data 
from the Myocardial Infarction National Audit Project (MINAP) in the UK show a rapid increase 
in the use of beta blockers, lipid-lowering drugs (statins) and aspirin in people discharged from 
hospital following a heart attack, with prescription rates for these drugs now standing at 92%, 
96% and 97% respectively in England, and 93%, 95% and 99% in Wales2.
1. Wood D (2007) Clinical reality of coronary prevention in Europe: a comparison of EURO ASPIRE I, II and III surveys. Lessons 
learned from the Euro Heart Survey Programme. Presentation at the European Society of Cardiology annual congress, Vienna, 
September 2007.
2. Royal College of Physicians (2007) How Hospitals Manage Heart Attacks. Sixth Public Report of the Myocardial Infarction 






Table 3.1 Rates of hospital discharges from CVD, 1970 to 
2005, Europe
Discharges per 100,000
 1970 1975 1980 1985 1990 1995 2000 2001 2002 2003 2004 2005
Albania      417 540 520 614 665 646 623
Andorra       586 610 799 799 729 727
Armenia   1,092 1,236 1,225 762 639 599 676 786 833 931
Austria     3,253 3,589 4,074 3,938 4,036 4,009 4,061 
Azerbaijan     1,481 595 472 484 515 541 570 572
Belarus      3,415 4,577 4,749 5,049 5,226 5,309 5,165
Belgium      2,235 2,377 2,352 2,324 2,275 2,303 
Bosnia and Herzegovina   964 905      
Bulgaria   1,451 1,790 1,779 1,774 1,869 2,013 2,292 2,600 2,911 2,840
Croatia    1,136 1,265 1,232 1,760 1,692 1,730 1,781 1,798 1,850
Cyprus   607 690 809 549 818 927 837 820 840 738
Czech Republic      3,051 3,379 3,431 3,495 3,592 3,635 3,743
Denmark     2,292 2,201 2,543 2,546 2,574 2,514 2,558 2,559
Estonia     2,338 2,664 3,239 3,237 3,168 3,309 3,387 
Finland     3,293 3,858 3,785 3,654 3,646 3,662 3,670 3,121
France       2,263 2,260 2,254 2,218 2,233 
Georgia     1,642 543 451 412 520 531 635 632
Germany      2,955 3,267 3,305 3,300 3,237 3,125 
Greece 778 978 1,191 1,404 1,593 2,010 2,309 2,432  
Hungary      3,171 4,239 4,039 4,248 4,448 4,949 4,977
Iceland     1,935  1,863 1,919 1,878 1,819 1,710 
Ireland      1,440 1,466 1,540 1,486 1,496 1,444 1,316
Israel     1,754 2,241 2,076 2,072 1,996 1,894 
Italy     2,128 2,349 2,582 2,572 2,552 2,444 
Kazakhstan     1,597 1,207 1,314 1,389 1,519 1,638 1,785 1,805
Kyrgyzstan   1,158 1,217 1,257 903 1,041 1,036 975 1,000 1,004 1,130
Latvia   1,898 2,423 2,445 2,598 3,144 3,137 3,175 3,289 3,399 3,636
Lithuania  1,634 1,978 2,628 2,687 3,201 4,102 4,164 4,231 4,369 4,483 4,570
Luxembourg       2,612 2,364 2,439 2,433 2,407 
Macedonia, TFYR    759  1,184 1,267 1,398 1,424 1,266 1,477 1,556
Malta       666 665 592 741 835 727
Moldova   1,316 1,626 1,727 1,580 1,315 1,311 1,558 1,983 2,032 2,023
Montenegro     1,059 1,249 1,325 1,448 1,585 1,759 1,733 1,636
Netherlands     1,420 1,589 1,409 1,374 1,416 1,456 1,549 
Norway      2,194 2,349 2,366 2,388 2,500 2,480 2,469
Poland   1,344 1,530 1,814 2,052   2,880 2,931 
Portugal      944 1,125 1,164 1,213 1,221 1,248 1,240
Romania   1,784 1,914 1,737 2,024 2,422 2,741 2,965 2,798 2,882 
Russian Federation     2,226 2,255 2,763 3,020 3,020 3,108 3,267 3,414
Serbia        1,590 1,571 1,691 1,798 1,796
Slovakia      2,534 2,443 2,569 2,539 2,501 2,564 2,679
Slovenia   1,286 1,391 1,424 1,560 1,685 1,738 1,718 1,745 1,792 
Spain     780 1,108 1,374 1,387 1,406 1,413 
Sweden     2,796 2,996 2,639 2,585 2,538 2,505 2,481 2,458
Switzerland        1,879 1,800 1,829 
Tajikistan     939 653 533 561 622 678 735 771
Turkey   270 390 531 896 909 962 1,051 1,153 1,220 
Turkmenistan      821   1,385 
Ukraine   2,119 2,601 2,792 2,568 2,612 2,791 2,964 3,105 3,280 3,462
United Kingdom       1,471 1,448 1,462 1,452 
Uzbekistan      1,217 959 1,059 1,178 1,234 1,269 1,394
European average     2,088 2,187 2,430 2,516 2,554 2,575 2,634 2,676
EU     1,977 2,194 2,411 2,435 2,463 2,444 2,458 2,454
Notes: Blank cells indicate that insufficient data were available for an estimate.





Table 3.2 Rates of hospital discharges from CHD, 1970 to 
2005, Europe
Discharges per 100,000
 1970 1975 1980 1985 1990 1995 2000 2001 2002 2003 2004 2005
Albania      121 157 146 172 191 195 187
Andorra        126 142 186 156 124
Armenia   334 437 521 318 282 258 288 324 350 382
Austria     785 917 924 960 981 992 1,035 
Azerbaijan     499 201 154 162 155 166 184 175
Belarus      1,621 2,212 2,296 2,278 2,452 2,541 2,569
Belgium      689 742 720 716 711 722 
Bosnia and Herzegovina   181 139      
Bulgaria   460 524 545 553 542 542 489 579 663 722
Croatia    295 334 309 495 457 458 490 491 503
Cyprus   223 293 339 222 332 360 293 248 269 253
Czech Republic      1,223 1,101 1,107 1,087 1,126 1,071 1,063
Denmark     700 684 790 803 844 817 831 823
Estonia     936 990 1,117 1,093 1,033 1,038 1,047 
Finland     1,153 1,369 1,160 1,140 1,128 1,138 1,091 923
France       497 510 513 514 
Georgia     680 194 193 186 236 263 307 308
Germany      947 1,060 1,011 1,003 960 916 
Greece 191 241 296 412 521 722 777 829  
Hungary      961 1,113 943 879 895 1,040 998
Iceland     790  724 763 769 738 639 
Ireland      477 480 504 495 504 465 451
Israel     834 1,012 872 857 814 747 
Italy     493 520 600 593 606 599 
Kazakhstan     522 436 419 519 521 552 583 606
Kyrgyzstan   324 321 365 156 322 324 307 328 367 385
Latvia   849 1,094 1,163 1,166 1,263 1,278 1,269 1,342 1,339 1,381
Lithuania    1,283 1,327 1,526 1,415 1,371 1,374 1,387 1,388 1,397
Luxembourg       819 868 907 931 865 
Macedonia, TFYR    141  321 480 573 623 579 789 909
Malta       184 204 185 260 304 271
Moldova   508 689 665 562 419 373 444 571 578 547
Montenegro      342 398 458 488 559 595 541
Netherlands     546 614 526 512 523 524 555 
Norway      890 876 944 938 981 971 953
Poland   332 397 541 598   958 889 
Portugal      225 277 274 285 283 285 277
Romania      637 752 809 848 723 649 
Russian Federation     888 936 1,103 1,168 1,178 1,201 1,258 1,313
Serbia          
Slovakia      1,089 955 954 917 874 861 884
Slovenia   309 313 349 347 366 381 394 401 392 
Spain     202 285 363 361 365 362 
Sweden     868 959 905 912 878 856 818 783
Switzerland        567 535 540 
Tajikistan      174 122 136 169 176 195 217
Turkey   38 56 99 144 206 216 239 277 289 
Turkmenistan      269   37 
Ukraine   614 719 728 665 1,197 1,284 1,380 1,450 1,555 1,646
United Kingdom       547 540 545 533 
Uzbekistan      321 300 347 392 398 444 443
European average     669 711 817 834 843 848 867 883
EU     581 657 714 707 711 701 688 686
Notes: Blank cells indicate that insufficient data were available for an estimate.






















































































































Table 3.3 Rates of hospital discharges from stroke, 1970 to 
2005, Europe
Discharges per 100,000
 1970 1975 1980 1985 1990 1995 2000 2001 2002 2003 2004 2005
Albania      45 80 82 80 91 91 94
Andorra        107 123 113 101 121
Armenia   101 128 194 132 130 129 147 163 161 172
Austria     646 680 847 639 654 617 629 
Azerbaijan     113 53 45 48 53 48 52 52
Belarus      564 896 912 949 1,037 1,083 1,063
Belgium      362 394 394 391 377 379 
Bosnia and Herzegovina   131 119      
Bulgaria   134 268 293 323 426 468 586 666 717 593
Croatia    233 297 281 411 394 396 392 383 409
Cyprus   116 131 143 89 140 149 137 146 149 109
Czech Republic      558 629 625 639 638 626 647
Denmark     430 394 452 435 424 411 404 384
Estonia     380 497 502 499 535 570 608 
Finland     681 820 658 661 645 646 633 561
France       216 215 213 218 
Georgia     193 58 74 72 79 80 93 95
Germany      487 462 464 462 453 422 
Greece 117 190 230 256 274 330 404 424  
Hungary      598 832 845 969 1,082 1,325 1,395
Iceland     244  237 228 206 254 206 
Ireland      234 251 259 252 248 253 170
Israel     203 288 295 293 283 285 
Italy     394 436 489 494 503 491 
Kazakhstan     176 169 210 234 278 293 321 351
Kyrgyzstan   91 107 145 124 153 155 142 142 149 174
Latvia   282 383 445 542 638 669 695 713 732 795
Lithuania    408 512 671 780 825 912 956 1,013 1,055
Luxembourg       233 184 164 164 175 
Macedonia, TFYR    121  199 251 240 224 221 250 269
Malta       79 77 65 73 61 54
Moldova   181 230 293 270 271 247 328 418 429 475
Montenegro      163 160 174 195 201 197 197
Netherlands     175 194 185 186 193 201 213 
Norway      382 320 321 328 353 345 342
Poland   130 159 191 232   370 418 
Portugal      287 336 345 350 338 336 329
Romania      280 328 404 442 461 516 
Russian Federation     370 458 595 653 668 684 720 760
Serbia          
Slovakia      491 452 473 475 465 473 518
Slovenia   219 268 249 255 230 230 222 225 228 
Spain     117 198 249 261 266 268 
Sweden     613 617 446 418 422 417 418 417
Switzerland        214 212 207 
Tajikistan     109 31 38 44 52 42 47 56
Turkey   27 50 71 106 148 158 166 184 202 
Turkmenistan      82   169 
Ukraine   244 358 486 467 540 585 629 671 723 770
United Kingdom       213 218 227 225 
Uzbekistan      112 79 94 99 102 105 116
European average     343 379 428 446 460 468 484 495
EU     319 351 373 378 389 390 398 397
Notes: Blank cells indicate that insufficient data were available for an estimate. 





Table 3.4 Rates of various procedures for treating CVD, around 2000, 
Europe
Procedures per million population
 Coronary Percutaneous Coronary Open Valve Coronary Pacemakers Implantable
 Angiograms coronary stents heart surgery artery bypass  cardioverter
  interventions  surgery  surgery  defibrillators
Austria 4,061 1,146 848 815  468
Belgium 4,798 1,536 931 1,230   857 48
Bulgaria 397 126 38 171 56 78 169 0
Croatia  443  305
Czech Republic 2,265 724 504 551 127 469 508 12
Denmark  825  993
Estonia 1,530 388 237 475 111 323 364 0
Finland 2,522 607 365 1,054 183 921 361 19
France 4,009 1,560 1,501 679 214 408 798 18
Germany  2,194  1,191
Greece 1,660 382 322    442 15
Hungary 1,667 249 191 525 119 281 368 14
Iceland 4,098 1,670 1,241 599 141 404 520
Ireland  537  718
Israel 4,719 2,377  1,266 156 879
Italy 2,846 962
Latvia 1,120 365 260 317 97 237 253 3
Lithuania 1,622 523 127 396 127 241 249 3
Macedonia, TFYR 967 415 385 151 21 115 80 1
Netherlands  1,091  904
Norway    954
Poland 1,520 527 298 438 66 303 358 7
Portugal 2,058 538 458 550 156 297 390 9
Romania 531 77 75 119 48 49 53 0
San Marino 2,253 789 789 113 188 413
Spain 1,646 581 449 435 174 162 371 38
Sweden  857  1,061  659
Switzerland 3,907 1,358 991 907  565 447 27
Turkey 1,348 249 150    24
United Kingdom  564 473 645 79 444 326 18
Notes: Data collated by the European Society of Cardiology from national registeries and reports from national cardiology societies. Data represent crude, non-
standardised numbers per million population. Rates for coronary artery bypass grafting include operations with and without valve surgery.





Figure 3.4a Crude rate of coronary artery bypass surgery, 






































































































































Figure 3.4b Crude rate of percutaneous coronary 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Smoking related mortality and morbidity
The long-term risk of smoking to individuals has been quantified in a 50-year cohort study of 
British doctors. Observing deaths in smokers and non-smokers over a 50-year period, the study 
concluded that “about half of all regular smokers will eventually be killed by their habit”1,2.
In Europe, about 20% of deaths from CVD in men and about 3% of deaths from CVD in women 
are due to smoking. (The equivalent figures for the 25 countries that made up the EU in 2006 
(EU-25) are 16% and 5% respectively). A higher proportion of premature deaths from CVD 
are due to smoking. In Europe, smoking causes 32% of CVD deaths in men aged 35 to 69 years 
and 6% of CVD deaths in women of the same age. In the EU-25 the equivalent figures are 28% 
and 13% respectively3.
Smoking is a major risk factor for many diseases other than CVD - notably cancer – which means 
that about 23% of all deaths in men living in Europe and about 5% of all deaths in women 
are due to smoking (23% and 7% in the EU-25) (Table 4.1). Over 1 million men and 200,000 
women in Europe die from smoking each year (of which 375,000 men and 78,000 women die 
from CVD). In the EU-25 506,000 men and 148,000 women die from smoking each year (of 
which 135,000 men and 48,000 women die from CVD) (Table 4.1). In the EU-25, around 32% 
of deaths in men aged 35 to 69 are due to smoking, and around 12% of deaths in women in the 
same age band (Table 4.2).
Research from the World Health Organization has estimated the impact of smoking on total 
disease burden (both mortality and morbidity) in terms of disability-adjusted life years (DALYs) 
lost. The World Health Report 2002 estimates that in developed countries around 12% of all 
disease burden and over 20% of CVD is due to smoking4.
The INTERHEART case-control study estimated that 29% of heart attacks in Western Europe and 
30% in Central and Eastern Europe are due to smoking, and that smokers and former smokers 
from these regions are at almost twice the risk of a heart attack compared to never smokers5.
Prevalence of smoking
Data from the World Health Organization’s “Health for All” database show that in all European 
countries (excluding Sweden) the prevalence of smoking is higher in men than it is in women. 
The difference in the prevalence of smoking between men and women is more marked in Eastern 
Europe than in Western Europe. For example, in Uzbekistan 24% of men smoke compared to 
only 1% of women, and in the Ukraine 62% of men smoke compared to only 17% of women 
(Table 4.3).
The prevalence of smoking in men is generally higher in Eastern and former Soviet countries 
– of the six European countries where more than half of men smoke, five were part of the Soviet 
Union; the sixth is Albania. In contrast, the male smoking rate in Western and Northern Europe 





This pattern is reversed for women, where smoking rates are very low in former Soviet states 
(6% in Georgia, 2% in Kyrgyzstan, 1% in Uzbekistan), low in Eastern and Central European 
countries but higher in Western and Northern European countries (Table 4.3 and Figures 4.3a 
and 4.3b).
Data from the Health Behaviour in School-aged Children survey on smoking among 15 year 
olds suggest that the traditional gender smoking patterns may be beginning to change. In more 
than half of the countries included in the survey in 2001/02, a greater proportion of 15 year old 
girls smoked than did boys. This was particularly the case for Western European countries (e.g. 
Portugal, 18% boys smoked at least once a week vs. 26% of girls). Smoking is more prevalent 
among 15 year old boys in Eastern European and former Soviet countries, but the gap between 
the sexes is less marked than is seen for adults (e.g. Russian Federation, 27% boys vs. 19% girls) 
(Table 4.4 and Figures 4.4a and 4.4b).
Passive smoking
The relationship between passive smoking and various non-communicable diseases has been 
studied since the mid 70s and a number of relationships between passive smoking and a variety 
of health problems – including CVD and cancer – have been observed6.
It is estimated that nearly 80,000 people in the EU-25 died from passive smoking in 2002, of 
which over 32,000 died from CHD. Over 25,000 passive smoking deaths were in the United 
Kingdom or Germany alone (Table 4.5).
Smokers tend to live with other smokers, so many of the deaths due to passive smoking are 
amongst smokers. But nearly 20,000 non-smokers died of passive smoking in the EU-25 in 2002, 
over half of which died from CHD (Table 4.5).
Trends in smoking prevalence
Over the past 25 years the prevalence of smoking amongst men has fallen in many Northern, 
Southern and Western European countries. The prevalence of smoking amongst women has also 
fallen in some, but not all, of these countries. In many countries where there has been a decline 
in the prevalence of smoking amongst women the decline has been less marked. For example 
between 1980 and 2005 the prevalence of smoking in Swedish men fell by nearly 60% but in 
Swedish women it fell by just 35%. This has meant that the difference in smoking prevalence 
between men and women has become less pronounced in recent years (Table 4.3). 
In Western European countries the male premature mortality rate due to smoking fell between 
1990 and 2000 (in some countries by between 40% and 50%), whereas this mortality rate 
increased in Belarus, the Russian Federation, Romania and Ukraine over this time period. The 
pattern is not as clear in women, where the premature mortality rate due to smoking increased 
in some Western (Netherlands, France) and Eastern (Hungary, Poland) European countries, and 
fell in other Western and Eastern countries (Table 4.2 and Figures 4.2c and 4.2d).
Trend data on the prevalence of smoking in 15 year olds around Europe seem to suggest a general 





1. Doll R, Peto R, Boreham J and Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. 
BMJ; 328: 1519-27.
2. For a detailed discussion of the health effects of tobacco use, see the recent European Commission publication prepared by the 
ASPECT (Analysis of the Science and Policy for European Control of Tobacco) consortium, European Commission (2004) Tobacco 
or Health in the EU: past, present and future. Luxembourg: Office for Official Publications of the European Union and http://
europa.eu.int/comm/health/ph_determinants/life_style/Tobacco/Documents/tobacco_fr_en.pdf
3. Peto R, Lopez AD, Boreham J, Thun M (2003) Mortality from smoking in developed countries 1950-2000. 2nd edition. Oxford: 
Oxford University Press. For table see www.heartstats.org.
4. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva: World 
Health Organization.
5. See table 4 and figure 5 from Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigo J, 
Lisheng A, on behalf of the INTERHEART Study Investigators (2004) Effect of potentially modifi able risk factors associated with 
myocardial infarction in 52 countries (the INTERHEART Study): case-control study. The Lancet; 364: 937-952.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.2 Total all-cause mortality rate and smoking 
attributable all-cause mortality rate by age and 
sex, Europe, 1950 to 2000
 All-cause mortality rate per 1,000
 1950  1975  1990  2000
 Not due to Due to Not due to Due to Not due to Due to Not due to Due to 
 smoking smoking smoking smoking smoking smoking smoking smoking
MEN AGED 35 TO 69
Austria   10.5 4.0 7.9 3.1 6.1 2.1
Belarus     11.1 6.3 15.7 7.9
Belgium   8.6 6.0 6.0 4.2 5.1 3.4
Bulgaria     10.9 4.7 11.4 4.5
Czech Republic     10.5 7.7 8.1 4.7
Denmark   8.2 3.7 7.7 3.8 6.4 2.6
Estonia     12.9 7.7 13.9 6.6
Finland   11.2 6.1 9.3 3.4 7.5 1.7
France 15.0 1.6 10.3 3.4 7.1 3.6 5.9 2.8
Germany   10.1 4.4 7.8 3.7 6.3 2.6
Greece   6.9 2.8 5.5 2.7 5.2 2.6
Hungary   11.3 4.4 12.3 8.5 11.1 7.8
Ireland 13.6 1.6 9.5 4.8 7.8 3.5 6.6 2.1
Italy   8.9 4.2 6.0 3.6 4.9 2.2
Latvia     12.4 7.3 14.8 6.6
Lithuania     11.3 6.7 12.5 5.4
Luxembourg   10.4 6.6 7.2 4.0 5.9 2.9
Malta   9.5 5.9 6.6 2.8 5.6 1.9
Moldova     13.0 5.8 14.4 4.2
Netherlands 8.3 2.0 6.9 5.4 5.8 3.7 5.3 2.5
Norway   9.2 2.0 7.6 2.1 5.5 1.6
Poland   10.4 4.8 10.5 7.7 9.2 6.0
Portugal   13.9 2.0 9.1 2.2 7.4 2.1
Romania     10.8 4.7 10.9 5.3
Russian Federation     12.2 8.4 19.1 9.9
Slovakia     12.1 7.5 10.3 5.8
Spain   9.2 2.8 6.2 2.9 5.3 2.7
Sweden   9.1 1.6 7.0 1.4 5.4 1.0
Switzerland   7.6 3.8 6.0 2.8 5.1 1.8
Ukraine     11.3 7.3 16.7 7.8
United Kingdom 10.8 5.6 8.0 6.3 6.9 3.7 5.9 2.1
Total EU-25   9.5 4.5 7.5 4.1 6.4 2.9
Total EU-25 (% of deaths due to smoking)   32%  35%  32%
MEN AGED 70 TO 79
Austria   66.2 18.4 48.2 10.9 38.7 8.2
Belarus     59.9 14.2 66.3 15.8
Belgium   60.6 22.3 41.2 20.0 34.1 16.2
Bulgaria     70.6 7.3 70.5 6.8
Czech Republic     69.3 19.5 51.3 13.8
Denmark   52.4 13.5 47.8 16.8 39.8 14.7
Estonia     63.9 14.8 55.6 17.2
Finland   61.7 20.0 50.8 15.5 40.2 11.1
France 82.1 0.9 61.1 10.8 39.8 9.3 34.2 7.5
Germany   67.2 19.5 50.4 13.3 38.1 10.2
Greece   45.8 10.9 41.2 10.9 35.9 9.9
Hungary   68.8 18.0 64.1 17.8 56.3 17.5
Ireland 81.6 0.2 62.3 15.3 53.0 18.3 46.8 13.9
Italy   60.0 12.9 40.8 12.9 32.6 11.2
Latvia     68.0 15.3 60.6 14.4
Lithuania     54.8 15.0 51.2 14.0
Luxembourg   62.5 19.7 44.0 18.6 35.9 12.1
Malta   81.5 7.7 53.1 12.5 45.9 7.8
Moldova     67.4 9.0 73.4 5.7
Netherlands 59.4 3.6 46.8 20.0 39.8 21.6 37.4 16.0
Norway   58.3 5.8 50.7 8.8 37.4 8.0
Poland   66.5 13.7 62.0 16.7 50.3 17.1
Portugal   88.6 5.4 56.0 6.9 45.8 6.7
Romania     64.0 6.5 60.8 7.8
Russian Federation     65.0 18.4 73.8 19.6
Slovakia     65.1 14.0 58.6 15.4
Spain   61.1 10.6 39.5 11.2 33.2 10.2
Sweden   56.8 7.4 48.2 5.9 37.5 5.0
Switzerland   51.7 12.1 40.9 11.7 33.4 8.5
Ukraine     61.9 15.8 73.0 15.5
United Kingdom 79.8 7.6 56.5 26.9 44.7 18.0 38.9 12.6
Total EU-25   61.9 16.8 46.6 13.8 38.2 11.2






 All-cause mortality rate per 1,000
 1950  1975  1990  2000
 Not due to Due to Not due to Due to Not due to Due to Not due to Due to 
 smoking smoking smoking smoking smoking smoking smoking smoking
WOMEN AGED 35 TO 69
Austria   6.9 0.4 4.8 0.4 3.5 0.5
Belarus     7.1 0.1 8.6 0.0
Belgium   7.0 0.2 4.5 0.4 3.8 0.5
Bulgaria     7.2 0.3 6.9 0.4
Czech Republic     7.0 0.7 5.0 0.7
Denmark   6.1 0.7 5.1 1.9 4.2 1.9
Estonia     7.6 0.6 7.1 0.3
Finland   6.7 0.1 4.8 0.2 3.8 0.2
France 9.8 0.0 6.1 0.0 4.1 0.1 3.4 0.2
Germany   7.2 0.2 5.2 0.4 3.8 0.5
Greece   5.3 0.3 3.9 0.2 3.2 0.2
Hungary   8.2 0.5 7.8 1.3 6.2 1.6
Ireland 12.2 0.0 6.8 1.4 5.0 1.3 4.2 1.0
Italy   6.1 0.2 4.2 0.2 3.2 0.2
Latvia     7.5 0.5 7.3 0.1
Lithuania     6.9 0.2 6.4 0.0
Luxembourg   8.0 0.0 5.4 0.6 3.9 0.5
Malta   9.1 0.0 5.3 0.0 4.2 0.1
Moldova     10.6 0.3 9.7 0.3
Netherlands 8.5 0.0 5.6 0.0 4.2 0.5 3.6 1.0
Norway   5.3 0.1 4.1 0.6 3.3 0.8
Poland   7.1 0.3 6.8 0.8 5.3 0.8
Portugal   7.6 0.0 5.3 0.0 4.1 0.1
Romania     7.6 0.5 7.1 0.5
Russian Federation     7.6 0.5 9.9 0.3
Slovakia     7.5 0.3 5.8 0.4
Spain   6.1 0.0 3.9 0.0 3.1 0.1
Sweden   5.4 0.2 4.0 0.5 3.3 0.7
Switzerland   5.3 0.1 3.8 0.3 3.1 0.4
Ukraine     7.3 0.5 8.9 0.3
United Kingdom 9.5 0.5 6.2 1.4 4.7 1.5 3.9 1.1
Total EU-25   6.6 0.3 4.9 0.5 3.9 0.5
Total EU-25 (% of deaths due to smoking)   5%  9%  12%
WOMEN AGED 70 TO 79
Austria   49.3 1.4 32.2 1.5 24.8 1.8
Belarus     44.8 0.4 48.4 0.0
Belgium   49.6 0.8 31.3 0.9 24.7 1.5
Bulgaria     53.7 0.9 52.4 0.9
Czech Republic     51.3 2.2 36.9 2.7
Denmark   37.4 2.0 30.3 5.7 25.4 8.9
Estonia     46.2 1.5 39.7 2.8
Finland   48.6 0.2 35.3 1.3 25.8 1.5
France 59.7 0.0 39.5 0.0 24.4 0.2 19.8 0.5
Germany   52.9 0.7 35.4 1.4 25.0 1.7
Greece   42.5 1.3 34.5 1.2 28.8 1.2
Hungary   56.4 3.0 47.7 4.3 40.5 4.1
Ireland 69.3 0.0 47.8 3.8 33.2 7.4 28.5 7.5
Italy   45.1 0.9 28.6 1.3 22.0 1.3
Latvia     48.1 1.2 40.4 1.5
Lithuania     41.4 1.6 35.0 0.0
Luxembourg   62.9 0.7 33.4 0.4 25.5 2.0
Malta   69.0 0.0 39.2 0.0 31.9 1.8
Moldova     53.3 2.1 54.8 0.0
Netherlands 59.9 0.0 40.7 0.0 28.6 1.2 25.2 3.1
Norway   39.2 0.0 30.9 1.7 22.4 3.7
Poland   50.5 0.9 44.7 2.3 36.3 2.3
Portugal   59.2 0.0 39.1 0.0 29.9 0.3
Romania     51.8 0.8 47.3 1.8
Russian Federation     47.4 2.0 52.9 1.8
Slovakia     47.4 1.4 42.3 1.2
Spain   47.9 0.0 28.1 0.0 21.9 0.0
Sweden   38.6 1.0 28.1 1.5 22.2 2.4
Switzerland   38.0 0.0 26.2 1.3 20.6 1.5
Ukraine     47.0 2.3 52.6 1.2
United Kingdom 63.8 0.8 42.4 3.7 30.6 6.2 25.5 6.9
Total EU-25   47.3 1.2 32.7 2.0 25.6 2.2
Total EU-25 (% of deaths due to smoking)   2%  6%  8%
Notes: Blank cells indicate that insufficent data were available for the estimate.
Source: Peto R, Lopez AD, Boreham J, Thun M (2003). Mortality from smoking in developed countries 1950-2000. 2nd edition (data 





Figure 4.2a All-cause mortality due to smoking, men aged 
























































































































































































Figure 4.2b All-cause mortality due to smoking, women 
































































































































































































Figure 4.2c  Change in mortality rate due to smoking 
between 1990 and 2000, men aged 35 to 69, 
Europe

































Difference in mortality rate per 1,000
Figure 4.2d Change in mortality rate due to smoking 
between 1990 and 2000, women aged 35 to 
69, Europe
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Table 4.3 Prevalence of smoking by sex, adults aged 15 and over, 
Europe, 1980 to 2005
 1980 1985 1990 
 -84 -89 -94 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
 % % % % % % % % % % % % % %
MEN
Albania   50      60   
Andorra      44     42  
Armenia       64   68    60
Austria  34 39 37  30
Belarus    55 55 53 55 54 54 53 53 53 54 54
Belgium 49 43 33 33 34 31 30 31 36 34 33 30 26 23
Bosnia and Herzegovina           49
Bulgaria  49  49 49     44
Croatia     34    34   34
Cyprus      29      38
Czech Republic   38  33   30 36 26 31 32 31
Denmark   39 38 36 34 34 35 32 34 31 31 29
Estonia   49  48  42  44  45  42
Finland 34 33 31 29 27 30 30 27 27 29 28 26 27 26
France 46  38  35    33  31 30
Georgia       53   53
Germany      43   39   37
Greece   53 49     47
Hungary   44 46    44 38   37
Iceland  33 29 27 28 28 25 25 23 25 22 25 22
Ireland 39 34 30 31   32    28  24 24
Israel 46 39 37 31 32 31 33  30  32 32 33 32
Italy   35 34 35 34 33 33 32 32 31
Kazakhstan     60     47   41
Kyrgyzstan      60  60  51   41 41
Latvia   49    53 49 51  51  47
Lithuania   43  47  49  52  44  39 42
Luxembourg  41 32 28   39  34  35 39 36 32
Macedonia, TFYR        40
Malta   40 34       30
Moldova         40 39 36 34 32 38
Netherlands 46 40 43 41 40 39 39 36 36 39 38 36 35 35
Norway 41 40 37 34 34 34 34 32 31 30 29 27 27 26
Poland   51  44   42   40  38 42
Portugal 42 39 38  33   33
Romania  44 37      32   33
Russian Federation   47    62  62 60   61
San Marino   28
Serbia         46
Slovakia   33    41
Slovenia   35  33   30  28    24
Spain   44 44  42    39  34
Sweden 34 28 24 22 21 17 17 19 17 18 16 17 15 14
Switzerland   34   39    27 31  24
Turkey  63          49
Ukraine    49     58     62
United Kingdom 39 34 29 29 29  28  29 28 27 28 26
Uzbekistan           24
WOMEN
Albania   8      18
Andorra      28     30
Armenia       1   3    2
Austria  17 24 13  19
Belarus    4 5 5 5 5 7 6 6 7 7 8
Belgium 27 26 22 24 27 22 23 26 26 22 25 25 15 16
Bosnia and Herzegovina           30
Bulgaria  17  17 24     23
Croatia    32     27   22
Cyprus      8      11
Czech Republic   26  20   17 22 20 18 23 20
Denmark   35 33 32 30 31 27 29 26 26 25 23
Estonia   19  22  20  20  18  21
Finland 18 18 20 20 18 20 20 20 20 20 20 19 20 18
France 17  20  21    21  22 21
Georgia       12   6
Germany      30   31   31
Greece   30 29     29
Hungary   27 28    21 23   25
Iceland  32 28 27 28 26 25 26 23 23 21 20 19
Ireland 32 30 28 28   31    26  24 24
Israel 30 29 26 25 25 25 25  24  18 18 18 19
Italy   17 17 18 18 18 17 17 17 17
Kazakhstan     7     8   9
Kyrgyzstan      12  12  5   2 2
Latvia   11    18 13 18  19  18
Lithuania   6  10  13  16  13  14 10
Luxembourg  25 26 28   27  26  25 26 26 22
Macedonia, TFYR        32
Malta   18 15       18
Moldova         2 2 2 2 2 4
Netherlands 33 32 31 31 32 32 31 32 29 30 29 28 27 26
Norway 32 33 33 32 33 33 32 32 31 30 29 25 25 24
Poland   29  24   23   25  26 25
Portugal 7 9 15  8   10
Romania  11 9      10   10
Russian Federation   12    11  13 16   15
San Marino   17
Serbia         31
Slovakia   16    15
Slovenia   23  21   20  20    22
Spain   21 25  25    25  22
Sweden 28 26 25 24 23 22 21 19 21 20 19 18 18 18
Switzerland   23   28    21 23  20
Turkey  24          18
Ukraine    21     14     17
United Kingdom 34 31 28 26 28  26  25 26 25 24 23
Uzbekistan           1
Notes: ‘Smoking’ defined as regular daily smoking. Blank cells indicate that data were not available. Estimates for grouped years are averages of all 
available annual estimates. 





Figure 4.3a Prevalence of smoking, men aged 15 and over, 






































































































































































































































































































































































Figure 4.3b Prevalence of smoking, women aged 15 and 










































































































































































































































































































































































Table 4.4 Prevalence of smoking by sex, 15 year olds, 1989/90 to 
2001/02, Europe
 BOYS    GIRLS
 1989/90 1993/94 1997/98 2001/02 1989/90 1993/94 1997/98 2001/02
 % % % % % % % %
Austria 23 29 30 26 20 31 36 37
Belgium (Flemish) 15 32 28 23 17 18 28 23
Belgium (French)  23  22  21  24
Croatia    23    25
Czech Republic  16 22 29  12 18 31
Denmark  14 20 17  24 28 21
Estonia  22 24 30  6 12 18
Finland 33 30 25 28 32 26 29 32
France  23 28 26  25 31 27
Germany  21 28 32  29 33 34
Greece   18 14   19 14
Hungary 31 25 36 28 20 19 28 26
Ireland   25 20   26 21
Israel   24 17   13 12
Italy  9  22  9  25
Latvia  33 37 29  14 19 21
Lithuania  15 24 35  4 10 18
Macedonia, TFYR    15    13
Malta    17    17
Netherlands    23    24
Norway 21 20 23 20 23 21 28 27
Poland 20 23 27 26 10 13 20 17
Portugal   19 18   14 26
Russian Federation  19 24 27  10 22 19
Slovakia  19 28   5 18 
Slovenia    30    30
Spain 18 20  24 27 27  32
Sweden 15 15 18 11 20 19 24 19
Switzerland  17 25 25  18 25 24
Ukraine    45    23
United Kingdom - England   25 21   33 28
United Kingdom - Northern Ireland  23 20   25 28 
United Kingdom - Scotland 16 21 22 16 18 26 28 23
United Kingdom - Wales 14 18 22 16 22 27 29 27
Notes: Smoking defined as smoking at least once a week.
 Data collected using representative national samples of schoolchildren, with the exception of France, Germany and the Russian Federation, where 
the samples were drawn from regions. In 1993/94 and 1997/98 these regions were Nancy and Toulouse, North Rhine-Westphalia, and St Petersburg 
respectively. In 2001/02 national samples were collected for France and the Russian Federation, and the regional sample for Germany was collected 
in Berlin, Hessen, North Rhine-Westphalia and Saxony.
Source: World Health Organization (2003) Young people’s health in context. Health Behaviour in School-aged Children (HBSC) study: international report 





























































































































































































































































































































































































































































Table 4.5  Estimated number of deaths attributable to 
passive smoking, adults aged 20 and over, 
Europe, 2002
 Deaths attributed to passive smoking in Deaths attributed to passive smoking 
 non-smokers in all adults
 CHD Stroke Total CHD Stroke Total
Austria 146 69 268 426 310 1,029
Belgium 243 164 522 719 727 2,133
Czech Republic 526 313 956 1,455 1,346 3,501
Denmark 217 114 428 627 505 1,714
Estonia 57 45 108 217 225 499
Finland 82 59 159 274 271 659
France 510 392 1,114 1,902 1,997 5,863
Germany 2,452 1,085 4,000 7,536 4,892 15,609
Greece 238 288 568 791 1,282 2,416
Hungary 555 313 959 1,766 1,421 3,940
Iceland 6 2 9 20 11 40
Ireland 89 31 140 294 145 566
Italy 835 625 1,778 2,513 2,788 7,180
Latvia 243 151 414 703 673 1,507
Lithuania 240 86 345 800 420 1,362
Luxembourg 10 7 20 30 33 86
Malta 11 4 17 31 19 59
Netherlands 269 161 562 806 729 2,332
Norway 98 46 176 267 188 626
Poland 933 692 1,826 3,390 3,514 8,720
Portugal 145 271 457 368 939 1,519
Slovakia 362 109 519 995 469 1,733
Slovenia 37 30 79 108 124 303
Spain 680 517 1,498 2,082 2,328 6,305
Sweden 91 43 151 267 184 539
Switzerland 163 62 267 470 270 1,003
United Kingdom 1,526 769 2,690 4,950 3,520 10,944
EU-25 10,239 6,279 19,242 32,342 28,591 79,449
Notes: Estimates based on population attributable proportions applied to routinely collected mortality data for passive smoking-
related conditions. See source for details.
Source: Smoke Free Partnership and the European Heart Network (2006) Lifting the smokescreen. 10 reasons for a smoke free 






Mortality and morbidity attributable to poor diets
It is universally recognised that a diet which is high in fat, salt and free sugars, and low in complex 
carbohydrates, fruit and vegetables increases the risk of chronic diseases – particularly CVD and 
cancer. These risks are outlined in the World Health Organization (WHO) report Diet, nutrition 
and the prevention of chronic diseases1. The more recent WHO report Global strategy on diet, 
physical activity and health outlined the need to improve diets in individuals and populations 
across the world2.
Whilst estimates of the impact of the total diet on mortality and morbidity are rare, the WHO 
have produced estimates of the contribution of individual elements of the diet. For example, the 
World Health Report 2002 estimates that around 4% of all disease burden in developed countries 
is caused by low fruit and vegetable consumption, and that just under 30% of CHD and almost 
20% of stroke in developed countries is due to fruit and vegetable consumption levels below 
600g per day3. 
Prevalence of poor diets
The data on diets in Europe presented here come from two sources: a questionnaire based survey 
carried out by the WHO Regional Office for Europe and food supply data published by the Food 
and Agriculture Organization (FAO) of the United Nations. 
For the questionnaire data the WHO requested information from dietary surveys, but dietary 
surveys should be interpreted with caution; surveys may be conducted using different methods, 
at different times and with differing base populations.
The data published by the FAO is calculated from the food produced in and imported into countries 
minus the food exported, fed to animals, or otherwise not available for human consumption. This 
amount is then divided by the population size. The FAO data thus provide an estimate of average 
availability per person rather than actual food consumption. It is therefore likely to give figures 
which are higher than actual food consumption in wealthy countries where substantial amounts 
of food are wasted, and to give figures which are lower than actual consumption in countries 
where people grow crops or raise animals in their back gardens or small holdings.
Data from the FAO and WHO suggest that the average diet in many European countries is 
poor. The WHO recommends that average fruit and vegetable intake should be at least 400g of 
fruit and vegetables per person per day1. The average adult intake of fruit and vegetables is less 
than 400g of fruit and vegetables per day in 20 of the 25 countries for which data are available 
(Table 5.1)4. 
Both the WHO survey and the FAO data show that fruit and vegetable intake is higher in Southern 
European countries than it is in Northern, Western, Central and Eastern European countries. 





and vegetables as in the UK, Sweden and Germany and three times as much as in Ukraine and 
Kazakhstan (Table 5.1, Table 5.2 and Figure 5.2a).
The WHO recommends that average fat intake should be between 15% and 30% of total energy 
intake, and average saturated fat intake should be no more than 10% of total energy intake1. 
Twenty one of 26 European countries where data are available do not meet the target for total fat 
(Table 5.3). The five countries that achieve the WHO recommendation are all in Eastern Europe 
- in general, Western European countries have an average fat intake of 35% or more of total 
energy, with some countries (Iceland, Belgium) over 40%. This East / West divide is also shown 
by the FAO data which suggest that, for example, fat intake is 35% lower in Romania than in 
Switzerland (Table 5.2 and Figure 5.2a). However, the FAO data do indicate generally lower 
levels of fat intake than the WHO data - with 22 out of 48 European countries for which FAO 
data is available meeting the goal of less than 30% of total energy from fat (Table 5.4).
The level of saturated fat intake is likely to be a better indicator of a poor diet than the level of 
total fat intake, as total fat also includes healthy vegetable fats. A secondary analysis of FAO food 
intake data has estimated the intake of saturated fat across Europe. This shows that the highest 
levels of saturated fat intake are in France, Switzerland, the Netherlands, Iceland, Belgium and 
Finland. Of the 46 European countries included in this analysis, less than half (22) meet the WHO 
population goal of less than 10% of energy from saturated fats (Table 5.5).
Trends in diets
FAO data show that over the past 30 years levels of fat consumption have remained stable while 
fruit and vegetable intake has increased in many Northern and Western European countries. For 
example, the average fruit and vegetable intake in Denmark more than doubled from the early 
seventies (307g per person per day) to the early 2000s (629g per person per day) (Table 5.4). In 
Southern, Central and Eastern European countries where fat intake was historically low, intakes 
are currently rising. Conversely fruit and vegetable consumption has not increased, and is even in 
decline in some countries (e.g. Cyprus). It appears that dietary patterns in Europe are converging 
(Table 5.2 and Table 5.4).
1. World Health Organization (2003) Diet, nutrition and the prevention of chronic diseases. Report of a Joint AHO/FAO Expert 
Consultation. Geneva: World Health Organization.
2. World Health Organization (2004) Global strategy on diet and physical activity. Geneva: World Health Organization. See www.
who.int/gb/ebwha/pdf_files/WHA57/A57_9-en.pdf
3. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Geneva: World 
Health Organization.
4. One of the countries that achieved an average consumption of fruit and vegetables greater than the 400g target (Italy) included 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5.2 Quantity of fruit and vegetables consumed, 
Europe, 1969/71 to 2001/03
Quantity consumed (g/person/day)
 1969- 1979- 1990- 1993- 1995- 2001-
 1971 1981 1992 1995 1997 2003
Albania    503  714
Armenia    493  591
Austria 498 566 570  526 603
Azerbaijan    348  506
Belarus    339  410
Bosnia and Herzegovina    476  577
Bulgaria    495  506
Croatia    426  554
Cyprus 999 852 746  711 766
Czech Republic    384  401
Denmark 307 323 424  443 629
Estonia    268  443
Finland 200 327 375  362 435
France 594 489 573  609 651
Georgia    378  357
Germany 456 466 558  530 561
Greece 939 1,059 1,183  1,162 1,145
Hungary    434  499
Iceland 171 242 330  351 447
Ireland 263 379 398  392 528
Israel 908 744 906  1,017 960
Italy 798 754 861  817 817
Kazakhstan    165  379
Kyrgyzstan    172  413
Latvia    301  400
Lithuania    302  440
Macedonia,TFYR    650  650
Malta 429 519 583  719 621
Moldova    467  413
Netherlands 469 495 626  575 661
Norway 353 393 419  443 504
Poland    454  429
Portugal 553 438 711  784 831
Romania    525  590
Russian Federation    297  380
Serbia and Montenegro    449  548
Slovakia    311  345
Slovenia    440  548
Spain 601 722 850  702 749
Sweden 327 360 427  421 508
Tajikistan    342  240
Turkey 798 850 862  877 909
Turkmenistan    336  357
Ukraine    340  384
United Kingdom 379 382 457  439 526
Uzbekistan    420  398
Notes: Estimates refer to the amount of food available for human consumption as estimated by the Food and Agriculture Organization 
food balance sheets. Actual food consumption may be lower than the quantity shown due to wastage and losses of food in the 
household. Fruit and vegetables do not include potatoes or other starchy roots, or pulses.
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Figure 5.2b Quantity of fruit and vegetables consumed, 





























Table 5.3 Percentage of total energy from fat by country 
and sex, adults, latest available year, Europe
 Year of survey Age group surveyed Men Women Total
Austria* Early 1990s 19+   38.2
Azerbaijan 1994/95 18+   16.4
Belgium* 1980/84 18+ 41.8 42.6 42.2
Croatia 1990 18+   36.0
Denmark* 1995 15-80 37.0 37.0 37.0
Estonia  1997 18+ 36.4 36.2 36.3
Finland* 1992 25-64   33.8
France* 1993/94 19-64 37.7 40.0 38.9
Germany - East* 1991/92 18-80 41.3 43.9 42.6
Germany - West* 1987/88 18-88 38.4 39.2 38.8
Hungary 1992/94 19+ 38.1 38.0 38.1
Iceland 1990 18+ 42.6 40.3 41.5
Ireland 1990 18+ 34.8 35.0 34.9
Italy* 1994/96 18-60 31.7 33.3 32.6
Kazakhstan 1996 18+   28.0
Latvia 1997 19-64 42.7 41.2 42.0
Lithuania 1997 18+ 45.4 42.6 44.0
Netherlands 1997/98 22-64   35.9
Norway 1993/94 16-79 31.0 30.0 30.5
Portugal 1980 19-64 37.5 31.5 34.5
Slovenia 1997 18+ 43.7 44.9 44.3
Spain - Catalonia* 1992 18-60 37.5 38.4 38.0
Sweden* 1989 15-74 37.0 36.0 36.5
Turkey 1984 18+   24.0
Ukraine 1997 18+   25.1
United Kingdom*  1986/87 16-64 38.0 39.0 38.5
Uzbekistan 1984 18+ 29.0 28.3 28.7
Source:  World Health Organization (1999), personal communication;































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.4b Percentage of energy from fat, selected 

































Table 5.5 Percentage of total energy from saturated fat, 
Europe, 1998
  %  %
Albania 9.2 Latvia 9.1
Armenia 7.3 Lithuania 7.7
Austria 13.9 Macedonia, TFYR 7.5
Azerbaijan 5.7 Malta 9.5
Belarus 10.2 Moldova 5.8
Belgium 14.5 Netherlands 14.6
Bosnia and Herzegovina 3.9 Norway 13.1
Bulgaria 9.8 Poland 10.7
Croatia 7.1 Portugal 10.6
Denmark 12.6 Romania 8.3
Estonia 10.6 Russian Federation 8.3
Finland 14.4 Slovakia 10.7
France 15.5 Slovenia 10.0
Georgia 5.2 Spain 10.9
Germany 13.7 Sweden 12.8
Greece 11.1 Switzerland 15.3
Hungary 11.8 Tajikistan 5.4
Iceland 14.6 Turkey 7.0
Ireland 13.5 Turkmenistan 10.1
Israel 8.8 Ukraine 7.6
Italy 11.8 United Kingdom 13.5
Kazakhstan 8.1 Uzbekistan 9.2
Kyrgyzstan 7.8 Yugoslavia 12.8
Notes: Data taken from the Food and Agriculture Organization.







Mortality and morbidity attributable to physical inactivity
A lack of physical activity increases the risk of CVD and other chronic diseases. The recent World 
Health Organization Global strategy on diet, physical activity and health outlined the urgent 
need to increase physical activity in individuals and populations across the world. To reduce the 
risk of CVD, the report recommends at least 30 minutes of regular moderate-intensity physical 
activity on most days1.
The World Health Report 2002 estimates that over 3% of all disease burden in developed countries 
is caused by physical inactivity, and that over 20% of CHD and 10% of stroke in developed 
countries is due to physical inactivity (less than 2.5 hours per week of moderate exercise or 1 
hour per week of vigorous exercise)2.
Prevalence of physical inactivity
The data on levels of physical inactivity across Europe are poor. There have only been three 
multinational surveys which have looked at levels of physical activity in Europe3,4,5, each carried 
out only in member states of the EU-156. The most recent was the 2005 Eurobarometer survey 
on physical activity, which asked a series of questions on the frequency and duration of vigorous 
activity, moderate activity and walking. While the results of the survey, designed to explore the 
prevalence of physical activity, are difficult to interpret, they show that the proportion of adults 
who regularly undertake physical activity is low.
For example, in 2005, over 40% of adults in EU-15 countries reported no moderate level physical 
activity in the past week, 16% no episodes of walking for 10 minutes or more and 66% spent in 
excess of 4 hours each day sitting. Only 18% reported daily moderate level physical activity, the 
frequency WHO suggests is required to reduce CVD7 (Table 6.1). The Eurobarometer survey also 
investigated work-related physical activity and showed that over half (59%) of the EU population 
get little or no physical activity at work5.
Levels of physical activity vary across the member states of EU-15 (Table and Figure 6.1).
1. World Health Organization (2004) Global strategy on diet and physical activity. WHO: Geneva. See www.who.int/gb/ebwha/pdf_fi 
les/WHA57/A57_9-en.pdf
2. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health 
Organization: Geneva.
3. Flynn A (1999) Pan EU survey of consumer attitudes to physical activity, body weight and health. Public Health Nutrition; 2(1a): 
0-160.
4. European Commission (2003) Physical Activity. Special Eurobarometer 183-6/ Wave 58.2- European Opinion Research Group 
EEIG. http://europa.eu.int/comm/public_opinion/archives/ebs/ebs_183_6_en.pdf
5. European Commission (2006) Health and Food Special Eurobarometer 246 / Wave 64.3 – TNS Opinion & Social http://ec.europa.
eu/health/ph_publication/eb_food_en.pdf
6. EU-15 are the 15 Member States of the EU prior to the expansions in 2004 and 2007.
7. The Eurobarometer survey does not report how many of those who undertook daily moderate-intensity physical activity were 
active for 30 minutes or more. This means the proportion of the adult EU-15 population achieving the overall recommended level 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mortality and morbidity attributable to alcohol 
consumption
While moderate alcohol consumption (one or two drinks a day) reduces the risk of CVD, at high 
levels of intake – particularly in ‘binges’ - the risk of CVD is increased. Alcohol consumption also 
increases the risk of liver cirrhosis, injuries and some forms of cancer. On balance, the positive 
effects of alcohol on the health of populations are generally outweighed by its negative effects. 
The World Health Report 2002 estimates that over 9% of all disease burden in developed 
countries is caused by alcohol consumption and that 2% of CHD and almost 5% of stroke in 
men in developed countries is due to alcohol. However, the impact of alcohol consumption in 
women in developed countries is estimated to be positive – if no alcohol were consumed, there 
would be a 3% increase in CHD and a 16% increase in stroke1.
Levels of and trends in alcohol consumption
Levels of recorded alcohol consumption vary considerably across Europe2. Data from 2003, the 
most recent comparable year, show that the amount of recorded alcohol consumption ranges 
from 0.4 litres (Tajikistan) to 18.0 litres (Luxembourg) per adult per year. There is a wide regional 
spread of countries with an above average level of alcohol consumption, including Northern 
(Estonia), Western (Ireland and Germany), Southern (France and Spain), Central (Czech Republic 
and Hungary) and Eastern (Republic of Moldova) countries (Table 7.1, Figure 7.1).
Levels of alcohol consumption are falling in many Northern, Southern and Western European 
countries but rising in a few. For example alcohol consumption in Portugal, France and Germany 
fell by 24%, 18% and 12% respectively between 1994 and 2003, but rose by 21% in Ireland. 
In Central and Eastern European countries alcohol consumption generally fell rapidly in the 
mid-to-late 1980s but has risen markedly again since then. Between 1994 and 2003 alcohol 
consumption in Kyrgyzstan, Lithuania and the Russian Federation rose by 16%, 94% and 21% 
respectively (Table 7.1).
1. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health 
Organization: Geneva.
2. Levels of actual alcohol consumption may vary less than levels of recorded consumption because there is probably much unrecorded 
consumption in countries with low recorded rates. For example, estimates from WHO suggest that unrecorded alcohol consumption 
is twice that of recorded consumption in Latvia and is four times that of recorded consumption in FYR Macedonia. For more details 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Risk of CVD is directly related to both systolic and diastolic blood pressure levels1. Both drug 
treatment and lifestyle changes - particularly weight loss, an increase in physical activity, and a 
reduction in salt and alcohol intake - can effectively lower blood pressure. 
The World Health Report 2002 estimates that around 11% of all disease burden in developed 
countries is caused by raised blood pressure, and that over 50% of CHD and almost 75% of 
stroke in developed countries is due to systolic blood pressure levels in excess of the theoretical 
minimum (115 mmHg)2. 
The INTERHEART case-control study estimated that 22% of heart attacks in Western Europe 
and 25% of heart attacks in Central and Eastern Europe are due to a history of high blood 
pressure, and that those with a history of hypertension are at just under twice the risk of a heart 
attack compared to those with no history of hypertension3. 
Reliable data on the prevalence of raised blood pressure across Europe comes from the MONICA 
Project. These data were collected using standardized methods between 1989 and 1997 for the 
35 to 64 year age range in 29 populations in 16 European countries. The results of this project 
show that the prevalence of systolic blood pressure levels of 160mmHg and above varies markedly 
across the populations sampled: from 2% (Toulouse, France) to 21% (North Karelia, Finland) 
in men and from 2% (Catalonia, Spain and Ghent, Belgium) to 17% (former East Germany) in 
women (Table and Figure 8.1). Trend data from the MONICA Project show that between the 
mid-1980s and mid-1990s the majority of European populations included in the study experienced 
a decline in average systolic blood pressure4.
More recently the WHO has provided estimates of systolic blood pressure for the European 
region for 2002 and projected estimates for 2005 and 2010. Among men aged 15 or over WHO 
data suggest that mean systolic blood pressure ranges between 118 mmHg (Turkey) and 140 
mmHg (Georgia). Among women aged 15 or over WHO data suggest that the mean systolic 
blood pressure ranges between 115 mmHg (Switzerland) and 135 mmHg (Georgia)5 (Table and 
Figure 8.2).
1. For example, a meta-analysis of prospective data on over one million adults has shown that for adults aged 40 to 69 years, each 
20mmHg increase in usual systolic blood pressure, or 10 mmHg increase in usual diastolic blood pressure, doubles the risk of death 
from CHD. Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-
analysis of individual data for one million adults in 61 prospective studies. The Lancet; 360: 1903-1913. 
2. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health 
Organization: Geneva.
3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigo J, Lisheng A, on behalf of the 
INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 
countries (the INTERHEART Study): case-control study. The Lancet; 364: 937-952. 
4. WHO Monica Project (2003) MONICA Monograph and Multimedia Sourcebook: World’s largest study of heart disease stroke, 
risk factors and population trends 1979-2002. Edited by Hugh Tunstall-Pedoe for the WHO MONICA Project. WHO: Geneva.





Table 8.1 Systolic blood pressure levels, adults aged 35 to 64, by 
sex, latest available data, MONICA European Project 
populations
 MEN WOMEN
MONICA population MONICA Year of Systolic blood pressure (mmHg) Systolic blood pressure (mmHg)
 population code survey 120 - <160 ≥160 Mean 120 - <160 ≥160 Mean
   % % mmHg % % mmHg
Belgium-Charleroi BEL-CHA  1990/93 73 4 131 50 5 125
Belgium-Ghent BEL-GHE 1990/92 70 3 129 49 2 122
Czech Republic CZE-CZE 1992 68 14 137 60 13 134
Denmark-Glostrup DEN-GLO 1991/92 55 5 126 46 3 121
Finland-Kuopio Province FIN-KUO 1992 73 16 140 64 16 139
Finland-North Karelia FIN-NKA 1992 69 21 142 63 14 137
Finland-Turku/Loimaa FIN-TUL 1992 78 12 139 69 12 135
France-Lille FRA-LIL 1995/96 73 10 135 62 6 129
France-Strasbourg FRA-STR 1995/97 70 11 135 52 8 127
France-Toulouse FRA-TOU 1994/96 57 2 125 34 3 117
Germany-Augsburg (rural) GER-AUR 1994/95 74 9 136 56 8 129
Germany-Augsburg (urban) GER-AUU 1995/95 74 11 137 58 9 131
Germany-Bremen GER-BRE 1991/92 68 8 132 59 8 128
Germany-East Germany  GER-EGE 1993/94 75 17 141 63 17 137
Iceland ICE-ICE 1993/94 57 4 125 44 4 121
Italy-Area Brianza ITA-BRI 1993/94 61 8 131 53 7 127
Italy-Friuli ITA-FRI 1994 73 14 140 67 10 134
Lithuania-Kaunas LTU-KAU 1992/93 71 13 137 58 15 134
Poland-Tarnobrzeg Voivodship POL-TAR 1992/93 68 9 134 57 14 134
Poland-Warsaw POL-WAR 1993 58 12 132 49 11 128
Russia-Moscow (control) RUS-MOC 1992/95 54 10 130 48 14 133
Russia-Novosibirsk (control) RUS-NOC 1995 65 9 132 56 11 131
Spain-Catalonia SPA-CAT 1994/96 47 2 121 38 2 118
Sweden-Gothenburg SWE-GOT 1994/96 68 11 134 60 8 129
Sweden-Northern Sweden SWE-NSW 1994 63 7 130 49 8 126
Switzerland-Ticino SWI-TIC 1993/93 69 6 132 52 4 124
Switzerland-Vaud/Fribourg SWI-VAF 1992/93 75 6 132 53 4 124
United Kingdom-Belfast UNK-BEL 1991/92 67 11 135 60 7 130
United Kingdom-Glasgow UNK-GLA 1995 69 8 133 52 7 126
Yugoslavia-Novi Sad YUG-NOS 1994/95 62 14 136 56 16 137
Notes: Age-standardized levels derived from means of two readings; consult WHO MONICA Project for details of measurement and age-standardization.
Source:  Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K, for the WHO MONICA Project (2004)  



























































































































Table 8.2 Mean systolic blood pressure by sex, adults aged 
15 and over, Europe, 2002, and projections for 
2005 and 2010
 MEN   WOMEN
 2002 2005 2010 2002 2005 2010
Albania 129 129 129 125 125 125
Armenia 122 122 122 123 123 123
Austria 129 128 127 122 122 120
Azerbaijan 122 122 122 123 123 123
Belarus 134 134 134 128 128 128
Belgium 127 127 127 119 119 119
Bosnia and Herzegovina 130 130 130 131 131 131
Bulgaria 132 132 132 125 125 125
Croatia 129 129 128 123 123 121
Cyprus 128 128 128 123 123 123
Czech Republic 130 129 128 123 122 121
Denmark 122 122 121 115 114 113
Estonia 131 131 131 122 122 122
Finland 131 130 129 125 123 121
France 129 127 124 125 123 119
Georgia 140 140 140 135 135 135
Germany 134 134 134 130 130 130
Greece 131 130 129 124 123 122
Hungary 134 134 134 126 126 126
Iceland 125 125 125 118 118 118
Ireland 129 129 128 123 123 121
Israel 128 127 126 121 120 119
Italy 129 127 125 122 120 118
Kazakhstan 131 131 131 128 128 128
Kyrgyzstan 122 122 122 123 123 123
Latvia 131 131 131 128 128 128
Lithuania 137 137 137 134 134 134
Luxembourg 126 125 124 121 120 119
Macedonia, TFYR 130 130 130 126 126 126
Malta 132 132 130 128 127 126
Moldova 131 131 131 128 128 128
Netherlands 131 130 129 122 121 120
Norway 129 129 128 123 123 121
Poland 129 129 129 123 123 123
Portugal 127 126 125 124 124 122
Romania 127 127 127 122 122 122
Russian Federation 129 129 129 127 127 127
Serbia and Montenegro 133 133 133 130 130 130
Slovakia 130 130 130 126 126 126
Slovenia 129 129 128 123 123 121
Spain 123 123 122 118 117 116
Sweden 131 131 131 125 125 125
Switzerland 126 125 124 115 114 112
Tajikistan 122 122 122 123 123 123
Turkey 118 118 118 119 119 119
Turkmenistan 122 122 122 123 123 123
Ukraine 127 127 127 125 125 125
United Kingdom 132 131 129 127 125 123
Uzbekistan 121 121 121 121 121 121
Notes: Age adjusted estimated systolic mean blood pressure values, aged 15 and above, Europe.
 2005 and 2010 data rely on estimation techniques - see source for details.







Risk of CVD is directly related to blood cholesterol levels. Blood cholesterol levels can be reduced 
by drugs, physical activity and by dietary changes, in particular a reduction in the consumption 
of saturated fat. 
Research from the World Health Organization highlights the importance of raised blood cholesterol 
as a risk factor for CHD. The World Health Report 2002 estimates that around 8% of all disease 
burden in developed countries is caused by raised blood cholesterol, and that over 60% of CHD 
and around 40% of ischaemic stroke in developed countries is due to total blood cholesterol 
levels in excess of the theoretical minimum (3.8 mmol/l)1.
The INTERHEART case-control study estimated that 45% of heart attacks in Western Europe 
and 35% of heart attacks in Central and Eastern Europe are due to abnormal blood lipids, and 
that those with abnormal lipids are at over three times the risk of a heart attack compared to 
those with normal lipids2.
Reliable information on the prevalence of raised cholesterol levels in Europe comes from the 
MONICA Project. These data were collected using standardized methods between 1989 and 
1997 for the 35 to 64 year age range in 25 populations in 15 European countries. The results 
show that the prevalence of cholesterol levels of 6.5mmol/l and above varies substantially across 
the populations sampled: from 8% (Novosibirsk, Russia) to 53% (Ticino, Switzerland) in men 
and from 15% (Novosibirsk, Russia) to 40% (Kaunas, Lithuania and Novi Sad, Yugoslavia) 
in women (Table and Figure 9.1). Trend data from the MONICA project show that between 
the mid-1980s and mid-1990s around half of the European populations included in the study 
experienced a decline in average blood cholesterol levels3.
More recently the WHO has provided estimates of mean total cholesterol for the European region 
for 2002 and projected estimates for 2005 and 2010. Among men aged 15 or over WHO data 
suggest that mean total cholesterol ranges between 4.5 mmol/l (Turkey) and 6.2 mmol/l (Serbia and 
Montenegro). Among women aged 15 or over WHO data suggest that the mean total cholesterol 
ranges between 4.6 mmol/l (Turkey) and 6.1 mmol/l4 (Norway) (Table 9.2).
1. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health 
Organization: Geneva.
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigo J, Lisheng A, on behalf of the 
INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 
countries (the INTERHEART Study): case-control study. The Lancet; 364: 937-952.
3. WHO Monica Project (2003) MONICA Monograph and Multimedia Sourcebook: World’s largest study of heart disease stroke,risk 
factors and population trends 1979-2002. Edited by Hugh Tunstall-Pedoe for the WHO MONICA Project. WHO: Geneva.



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 9.2 Mean total cholesterol by sex, adults aged 15 
and over, Europe, 2002, and projections for 
2005 and 2010
Mean mmol/l total cholesterol MEN   WOMEN
 2002 2005 2010 2002 2005 2010
Albania 5.2 5.2 5.2 5.1 5.1 5.1
Armenia 5.1 5.1 5.1 5.1 5.1 5.1
Austria 5.5 5.4 5.3 5.5 5.5 5.4
Azerbaijan 5.0 5.0 5.0 5.0 5.0 5.0
Belarus 6.0 6.0 6.0 5.3 5.3 5.3
Belgium 5.5 5.5 5.4 5.6 5.5 5.4
Bosnia and Herzegovina 5.1 5.1 5.1 5.1 5.1 5.1
Bulgaria 5.7 5.7 5.7 5.9 5.9 5.9
Croatia 5.5 5.5 5.4 5.4 5.3 5.2
Cyprus 6.0 6.0 6.1 5.7 5.8 5.8
Czech Republic 5.5 5.4 5.3 5.5 5.5 5.4
Denmark 5.4 5.4 5.3 5.3 5.2 5.1
Estonia 5.2 5.0 5.0 5.3 5.2 5.2
Finland 5.4 5.3 5.2 5.3 5.2 5.1
France 5.5 5.4 5.3 5.4 5.3 5.2
Georgia 5.0 5.0 5.0 5.0 5.0 5.0
Germany 5.7 5.7 5.6 5.8 5.7 5.6
Greece 4.8 4.8 4.7 4.7 4.7 4.6
Hungary 5.4 5.4 5.4 5.1 5.1 5.1
Iceland 5.7 5.6 5.5 5.5 5.4 5.3
Ireland 5.6 5.5 5.4 5.4 5.4 5.3
Israel 5.5 5.6 5.5 5.8 6.0 5.9
Italy 5.2 5.2 5.1 5.1 5.1 5.0
Kazakhstan 5.2 5.2 5.2 5.2 5.2 5.2
Kyrgyzstan 5.1 5.1 5.1 5.0 5.0 5.0
Latvia 5.3 5.3 5.3 5.3 5.3 5.3
Lithuania 5.3 5.3 5.3 5.4 5.4 5.4
Luxembourg 6.1 6.0 5.9 5.9 5.9 5.8
Macedonia, TFYR 5.1 5.1 5.1 5.1 5.1 5.1
Malta 5.7 5.7 5.6 5.9 5.9 5.8
Moldova 5.0 5.0 5.0 5.0 5.0 5.0
Netherlands 4.9 4.8 4.7 5.0 4.9 4.8
Norway 5.7 5.6 5.5 6.1 6.0 5.9
Poland 5.2 5.2 5.2 5.1 5.1 5.1
Portugal 5.3 5.2 5.1 5.1 5.1 5.0
Romania 5.1 5.1 5.1 5.0 5.0 5.0
Russian Federation 4.9 4.9 4.9 4.9 4.9 4.9
Serbia and Montenegro 6.2 6.2 6.2 5.9 5.9 5.9
Slovakia 5.0 5.0 5.0 5.1 5.1 5.1
Slovenia 5.3 5.2 5.1 5.3 5.2 5.1
Spain 5.1 5.1 5.0 5.1 5.1 5.0
Sweden 5.3 5.2 5.1 5.3 5.2 5.1
Switzerland 5.3 5.1 5.0 5.3 5.2 5.1
Tajikistan 4.9 4.9 4.9 4.9 4.9 4.9
Turkey 4.5 4.5 4.5 4.6 4.6 4.6
Turkmenistan 5.2 5.2 5.2 5.2 5.2 5.2
Ukraine 5.1 5.1 5.1 5.2 5.2 5.2
United Kingdom 5.2 5.1 5.0 5.2 5.1 5.0
Uzbekistan 5.0 5.0 5.0 5.0 5.0 5.0
Notes: Age adjusted estimated blood cholesterol values aged 15 and above, Europe.
 2005 and 2010 data rely on estimation techniques - see source for details.







Overweight and obesity increase the risk of CVD. As well as being an independent risk factor, 
obesity is also a major risk factor for high blood pressure, raised blood cholesterol, diabetes and 
impaired glucose tolerance1.
The World Health Organization’s World Health Report 2002 estimates that over 7% of all disease 
burden in developed countries is caused by raised Body Mass Index (BMI), and that around a third 
of CHD and ischaemic stroke and almost 60% of hypertensive disease in developed countries is 
due to levels of BMI in excess of the theoretical minimum (21 kg/m2)2. 
The INTERHEART case-control study estimated that 63% of heart attacks in Western Europe 
and 28% of heart attacks in Central and Eastern Europe are due to abdominal obesity (a high 
waist to hip ratio), and those with abdominal obesity are at over twice the risk of a heart attack 
compared to those without3. This study also found that raised abdominal obesity was a better 
predictor of heart attack than raised BMI.
Prevalence of overweight and obesity
Data on the prevalence of overweight and obesity in Europe usually are taken from national 
health surveys. Because of differences in the survey designs (sampling frames, age of population 
surveyed etc.) the results are difficult to compare. Truly comparable data are available from the 
results of single pan-European studies; the most recent study that includes the prevalence of 
overweight and obesity is the WHO MONICA project. The latest results of this project showed 
that in the mid-1990s between 8% (Moscow, Russia) and 24% (Kuopio Province, Finland and 
rural Augsburg, Germany) of men aged 35 to 64 were obese. For women aged 35 to 64 between 
10% (Toulouse in France, Gothenburg in Sweden, and Vaud/Fribourg in Switzerland) and 36% 
(Tanobrzeg Vovoidship, Poland) were obese (Table 10.1).
Recent WHO estimates (based on national survey data) suggest that the prevalence of obesity in 
men aged 15 and above ranges from 5% in Uzbekistan to 26% in Greece, and the prevalence in 
women ranges from 6% in Norway to 30% in Turkey (Table 10.2 and Figures 10.2 and 10.2b). 
There does not appear to be any clear geographical pattern to the variation in the prevalence of 
obesity in either men or women.
WHO data suggest that the average BMI of men aged 15 and over in 2002 ranged from 23.2 in 
Tajikistan to 27.6 in Greece, and the average BMI of women ranged from 23.5 in both Estonia 
and France to 27.9 in Malta (Table 10.3 and Figures 10.3a and 10.3b).
Overweight and obesity in children





than in adults. Constant changes in body composition during growth mean that the relationship 
between BMI and adiposity during childhood is age dependent, and further complicated by race 
and gender. While there is no clear agreement on the best way to define overweight and obesity 
in children, the International Obesity Task Force (IOTF) has developed a new international 
classification based on age and sex-specific BMI cut-off points.
The most recent data on the prevalence of childhood obesity around Europe is hampered by 
differential definitions of obesity, and differential methods of data collection. The results suggest 
that the highest levels of childhood obesity in Europe are found in the United Kingdom, Italy 
and Spain. In both Italy and the United kingdom there are nearly twice as many boys aged 5 to 
17 who are obese than in Germany or the Czech Republic (Table 10.4). 
Trends in overweight and obesity prevalence
Trend data from the MONICA Project show that between the mid-1980s and mid-1990s the 
majority of European populations included in the study experienced an increase in average 
BMI4.
The WHO have made projections of expected average BMI of men and women in the year 2010, 
based on trend data from national survey data. Only the women in Kazakhstan (out of all of 
the countries in the WHO European region) were expected to see a fall in average BMI between 
2002 and 2010 (Table 10.3 and Figures 10.3c and 10.3d).
There are complex patterns in trends for obesity in childhood. Data from the International 
Association for the Study of Obesity suggest that childhood obesity in Europe has increased 
steadily over the past two or three decades5. In England, for example, the prevalence of obesity 
in children aged 4 to 11 years increased by over 50% between 1974 and 1994.
1. World Health Organization (2000) Obesity – preventing and managing the global epidemic. Report of a WHO Consultation on 
Obesity. World Health Organization: Geneva.
2. World Health Organization (2002) The World Health Report 2002. Reducing Risks, Promoting Healthy Life. World Health 
Organization: Geneva.
3. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the 
INTERHEART Study Investigators (2004) Effect of potentially modifi able risk factors associated with myocardial infarction in 52 
countries (the INTERHEART Study): case-control study. The Lancet; 364: 937-952.
4. WHO Monica Project (2003) MONICA Monograph and Multimedia Sourcebook: World’s largest study of heart disease stroke, 
risk factors and population trends 1979-2002. Edited by Hugh Tunstall-Pedoe for the WHO MONICA Project. World Health 
Organization: Geneva
5. For a discussion on childhood obesity in Europe and further details of the IOTF classification system see Lobstein T, Baur L and 
Uauy R, for the IASO International Obesity Task Force (2004) Obesity in children and young people: A crisis in public health. 





Table 10.1  Prevalence of overweight and obesity, adults 
aged 35 to 64, by sex, latest available data, 
MONICA Project populations
MONICA Population MONICA Year of Overweight Obese Mean BMI 
 population code survey % % kg/m2
MEN
Belgium - Charleroi BEL-CHA 1990/93 47 19 27.1
Belgium - Ghent BEL-GHE 1990/92 52 13 26.4
Czech Republic CZE-CZE 1992 52 23 27.6
Denmark - Glostrup DEN-GLO 1991/92 41 13 26.0
Finland - Kuopio Province FIN-KUO 1992 46 24 27.3
Finland - North Karelia FIN-NKA 1992 49 23 27.5
Finland - Turku, Loimaa FIN-TUL 1992 46 22 27.1
France - Lille FRA-LIL 1995/96 40 17 26.4
France - Strasbourg FRA-STR 1995/97 51 22 27.3
France - Toulouse FRA-TOU 1994/96 49 13 26.1
Germany - Augsburg (rural) GER-AUR 1994/95 55 24 27.8
Germany - Augsburg (urban) GER-AUU 1994/95 54 17 27.1
Germany - Bremen GER-BRE 1991/92 50 16 26.8
Germany - East Germany GER-EGE 1993/94 51 18 26.9
Iceland ICE-ICE 1993/94 50 16 26.8
Italy - Area Brianza ITA-BRI 1993/94 50 14 26.4
Italy - Friuli ITA-FRI 1994 51 17 26.9
Lithuania - Kaunas LTU-KAU 1992/93 47 20 27.1
Poland - Tarnobrzeg Voivodship POL-TAR 1992/93 41 15 25.9
Poland - Warsaw POL-WAR 1993 45 22 27.1
Russia - Moscow (control) RUS-MOC 1992/95 38 8 25.2
Russia - Novosibirsk (control) RUS-NOC 1995 35 17 25.9
Spain - Catalonia SPA-CAT 1994/96 53 16 26.7
Sweden - Gothenburg SWE-GOT 1994/96 47 13 26.2
Sweden - Northern Sweden SWE-NSW 1994 50 14 26.4
Switzerland - Ticino SWI-TIC 1992/93 53 13 26.5
Switzerland - Vaud, Fribourg SWI-VAF 1992/93 47 16 26.5
United Kingdom - Belfast UNK-BEL 1991/92 49 14 26.3
United Kingdom - Glasgow UNK-GLA 1995 42 23 26.8
Yugoslavia - Novi Sad YUG-NOS 1994/95 49 20 27.3
WOMEN
Belgium - Charleroi BEL-CHA 1990/93 33 24 26.8
Belgium - Ghent BEL-GHE 1990/92 40 16 26.1
Czech Republic CZE-CZE 1992 35 30 27.8
Denmark - Glostrup DEN-GLO 1991/92 26 12 24.7
Finland - Kuopio Province FIN-KUO 1992 34 26 27.1
Finland - North Karelia FIN-NKA 1992 37 24 27.1
Finland - Turku, Loimaa FIN-TUL 1992 35 19 26.2
France - Lille FRA-LIL 1995/96 30 22 26.4
France - Strasbourg FRA-STR 1995/97 31 19 26.2
France - Toulouse FRA-TOU 1994/96 24 10 24.5
Germany - Augsburg (rural) GER-AUR 1994/95 33 23 26.8
Germany - Augsburg (urban) GER-AUU 1994/95 36 21 26.5
Germany - Bremen GER-BRE 1991/92 36 19 26.3
Germany - East Germany GER-EGE 1993/94 37 18 26.4
Iceland ICE-ICE 1993/94 36 18 26.3
Italy - Area Brianza ITA-BRI 1993/94 29 18 25.5
Italy - Friuli ITA-FRI 1994 31 19 25.8
Lithuania - Kaunas LTU-KAU 1992/93 34 32 28.0
Poland - Tarnobrzeg Voivodship POL-TAR 1992/93 36 36 28.5
Poland - Warsaw POL-WAR 1993 35 29 27.5
Russia - Moscow (control) RUS-MOC 1992/95 33 22 26.5
Russia - Novosibirsk (control) RUS-NOC 1995 33 35 28.5
Spain - Catalonia SPA-CAT 1994/96 42 25 27.4
Sweden - Gothenburg SWE-GOT 1994/96 31 10 24.9
Sweden - Northern Sweden SWE-NSW 1994 34 14 25.7
Switzerland - Ticino SWI-TIC 1992/93 27 16 25.3
Switzerland - Vaud, Fribourg SWI-VAF 1992/93 31 10 24.7
United Kingdom - Belfast UNK-BEL 1991/92 30 16 25.6
United Kingdom - Glasgow UNK-GLA 1995 36 23 26.9
Yugoslavia - Novi Sad YUG-NOS 1994/95 36 32 27.8
Notes: Overweight refers to a body mass index (BMI) of greater than or equal to 25 and less than 30 kg/m2. Obese refers to a BMI 
of greater than or equal to 30kg/m2.
 Age-standardized levels - refer to source for details of measurement and age-standardization.
Source: Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K, for the WHO MONICA Project (2001) Trends in 





Table 10.2 Prevalence of obesity by sex, adults aged 15 
and over, latest available year, Europe
 Survey MEN WOMEN
 year % %
Armenia 2000/01  14
Azerbaijan 2001  12
Belgium * 2004 12 13
Bosnia and Herzegovina 2002 17 25
Croatia 2003 22 23
Czech Republic * 2002 14 16
Denmark * 2000 10 9
Estonia * 2004 14 15
Finland 2000/01 21 24
Germany * 2002/03 14 12
Greece 2004 26 18
Hungary * 2003/04 17 18
Iceland * 2002 12 12
Ireland * 2002 14 12
Israel 1999/2001 20 25
Italy * 2003 9 9
Kazakhstan 1999  13
Kyrgyzstan 1997  9
Latvia * 2004 12 20
Lithuania * 2004 14 17
Macedonia, TFYR 1999  11
Malta * 2002 25 21
Netherlands 1998/2001 10 12
Norway * 1998 7 6
Poland 2000 16 20
Romania 1997 9 19
Serbia and Montenegro 2000 14 20
Slovenia * 2001 17 14
Spain 2003 13 14
Sweden * 2002/03 10 10
Switzerland * 2002 8 8
Turkey 1997 13 30
Turkmenistan 2000  10
Uzbekistan 2002 5 7
Notes: * estimate from self-reported data. Obesity is defined as a body mass index >= 30kg/m2. Blank cells indicate that insufficient data 
were available for an estimate. Comparisons between countries may be limited owing to differences in sample characteristics or 
survey years.





Figure 10.2a Prevalence of obesity, men aged 15 and over, 
















































































































































































































































* estimate from self-reported data
Figure 10.2b Prevalence of obesity, women aged 15 and 









































































































































































































































































































Table 10.3 Mean Body Mass Index by sex, adults aged 15 and over, 
2002 and projections for 2005 and 2010, Europe
 MEN WOMEN
 Estimates for Projection for Projection for Estimates for Projection for Projection for
 2002  2005 2010 2002  2005 2010
 – kg/m2 – kg/m2 – kg/m2 – kg/m2 – kg/m2 – kg/m2
Albania 26.0 26.0 26.0 25.8 25.8 25.8
Andorra 26.0 26.2 26.3 27.1 27.3 27.6
Armenia 25.5 25.5 25.5 25.7 25.7 25.7
Austria 26.2 26.5 26.7 25.9 25.9 26.1
Azerbaijan 25.9 25.9 25.9 26.4 26.4 26.4
Belarus 26.3 26.3 26.3 27.7 27.7 27.7
Belgium 25.1 25.4 25.6 24.2 24.2 24.5
Bosnia and Herzegovina 25.8 25.8 25.8 25.7 25.7 25.7
Bulgaria 26.3 26.3 26.3 25.0 25.0 25.0
Croatia 26.2 26.3 26.6 24.9 25.0 25.3
Cyprus 25.2 25.3 25.5 26.2 26.4 26.7
Czech Republic 26.0 26.1 26.4 25.2 25.3 25.6
Denmark 25.2 25.3 25.6 23.9 24.0 24.2
Estonia 25.1 25.1 25.1 23.5 23.5 23.5
Finland 26.5 26.6 26.8 25.6 25.6 25.9
France 24.6 24.7 25.0 23.5 23.7 23.9
Georgia 24.0 24.1 24.3 25.0 25.2 25.6
Germany 26.6 26.7 27.0 25.8 26.0 26.2
Greece 27.6 27.7 28.0 26.5 26.7 27.0
Hungary 25.8 25.8 25.8 25.1 25.1 25.1
Iceland 25.9 26.1 26.3 26.4 26.6 26.8
Ireland 25.1 25.3 25.5 24.2 24.3 24.5
Israel 25.8 25.9 26.2 26.3 26.5 26.7
Italy 25.4 25.5 25.7 24.1 24.2 24.4
Kazakhstan 24.6 24.6 24.6 24.4 24.0 24.0
Kyrgyzstan 23.6 23.6 23.6 24.7 24.7 24.7
Latvia 25.1 25.1 25.1 24.8 24.8 24.8
Lithuania 26.3 26.3 26.3 24.7 24.7 24.7
Luxembourg 25.4 25.6 25.8 25.4 25.6 25.8
Macedonia, TFYR 23.9 23.9 23.9 26.4 26.4 26.4
Malta 27.2 27.4 27.7 27.9 28.1 28.3
Moldova 23.6 23.7 24.0 24.6 24.9 25.2
Monaco 25.9 26.0 26.2 26.9 27.1 27.4
Netherlands 24.8 25.0 25.2 24.4 24.6 24.8
Norway 25.4 25.5 25.8 24.3 24.4 24.7
Poland 25.3 25.3 25.3 24.8 24.8 24.8
Portugal 25.7 25.9 26.1 25.0 25.2 25.5
Romania 23.9 23.9 23.9 24.2 24.2 24.2
Russian Federation 24.9 24.9 24.9 25.9 25.9 25.9
San Marino 25.8 25.9 26.1 26.9 27.1 27.4
Serbia and Montenegro 26.3 26.3 26.3 25.4 25.4 25.4
Slovakia 25.2 25.3 25.5 26.2 26.4 26.8
Slovenia 25.6 25.7 25.9 26.6 26.8 27.1
Spain 25.8 25.8 26.0 24.9 25.2 25.4
Sweden 25.3 25.5 25.8 24.5 24.6 24.9
Switzerland 25.4 25.6 25.8 25.6 25.9 26.2
Tajikistan 23.2 23.4 23.6 24.3 24.5 24.9
Turkey 25.0 25.0 25.0 27.6 27.6 27.6
Turkmenistan 25.0 25.0 25.0 24.9 24.9 24.9
Ukraine 24.3 24.3 24.3 25.4 25.4 25.4
United Kingdom 26.4 26.8 27.0 26.2 26.7 26.9
Uzbekistan 24.4 24.4 24.4 24.7 25.4 25.4
Notes: Values age-adjusted to the WHO standard population.






Figure 10.3a Mean Body Mass Index, men aged 15 and 
over, 2002, Europe






















Figure 10.3c Mean Body Mass Index, men aged 15 and 
over, projections for 2010, Europe
Figure 10.3d Mean Body Mass Index, women aged 15 and 





















Table 10.4 Prevalence of overweight and obesity in 
children, latest available year, Europe
 Survey Age range BOYS GIRLS
 year  % %
Austria † 2003 8-12 23 17
Belgium † 1998/99 5-15 28 27
Bulgaria 1998 7-17 19 16
Cyprus 1999/2000 6-17 25 23
Czech Republic 2001 5-17 15 13
Denmark 1996/97 5-16 14 15
Estonia * 2001/02 13 and 15 19 9
Finland * 1999 12, 14 and 16 17 10
France 2000 7-9 18 18
Germany  1995 5-17 14 14
Greece 2003 13-17 30 16
Hungary 1993/94 10 and 15 18 16
Iceland 1998 9 22 26
Italy 1993/2001 5-17 27 25
Malta * 2001 13 and 15 31 20
Netherlands 1997 5-17 9 12
Poland 2001 7-9 14 15
Portugal 2002/03 7-9 30 34
Russian Federation 1992 5-17 24 20
Slovakia 1995/99 11-17 10 8
Spain 2000/02 13-14 35 32
Sweden 2001 6-11 18 27
Switzerland 2002 6-12 17 19
Turkey 2001 12-17 11 10
United Kingdom - England 2004 5-17 29 29
Notes: Body Mass Index cut off to define overweight and obesity from the International Obesity Task Force method, except for 
countries marked †, where the cut-off was based on the 90th centile (Austria) and the 85th centile (Belgium). See source for 
details.
 Estimates for countries marked * are based on self report.






There are two main types of diabetes: Type 1 and Type 2 diabetes1. Diabetes not only substantially 
increases the risk of CVD but also magnifies the effect of other risk factors for CVD such as raised 
cholesterol levels, raised blood pressure, smoking and obesity. 
The INTERHEART case-control study estimated that people with diagnosed diabetes are at three 
times the risk of a heart attack compared to those without2.
There are two data sources on the prevalence of diabetes in Europe. The WHO European Health 
for All database compiles data from national diabetes registers, where available, or from routine 
reporting systems. The prevalence of diabetes is highest in Malta (7.6%) and the Czech Republic 
(7.2%).These data show the prevalence of diagnosed diabetes is increasing in nearly all countries 
of Europe (Table 11.1). 
The WHO data, however, greatly underestimate the true prevalence of diabetes in the population 
as around 50% of diabetes is undiagnosed. The International Diabetes Federation’s Diabetes Atlas 
collates population-based prevalence studies across Europe, and reports data on diagnosed and 
undiagnosed diabetes combined (Table 11.2). This study estimates an overall European prevalence 
of 7.8%, with over 48 million adults aged 20 to 79 years in Europe living with diabetes in 2003. 
Rates are generally highest in countries of Central and Eastern Europe (Fig 11.2).
1. Diabetes is characterized by high blood glucose levels. It arises when the pancreas fails to make enough insulin or when the body 
cannot effectively make use of the insulin produced or both. The chronic high blood glucose levels (hyperglycaemia) that result 
are associated with long-term damage, dysfunction and failure of various organs, especially the eyes, kidneys, nerves, heart and 
blood vessels. Type 1 diabetes results from an autoimmune destruction of the cells in the pancreas (the pancreas produces insulin). 
People with Type 1 diabetes must take daily injections of insulin for survival. Type 2 diabetes, which accounts for about 90% of all 
diabetes, is characterized by an inability on the part of the body to respond to insulin (insulin resistance) and/or abnormal insulin 
secretion. People with Type 2 diabetes are not usually treated with insulin. There are a number of other less common types of 
diabetes including gestational diabetes. This occasionally occurs during pregnancy in women not previously diagnosed with diabetes 
and is a marker of greater risk of developing Type 2 diabetes in later life.
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigo J, Lisheng A, on behalf of the 
INTERHEART Study Investigators (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































CVD has major economic costs as well as human costs for Europe.
Health care costs
CVD cost the health care systems of the EU just under €110 billion in 20061,2. This represents a 
cost per capita of €223 per annum, around 10% of the total health care expenditure across the 
EU. The cost of inpatient hospital care for people who have CVD accounted for about 54% of 
these costs, and that of drugs for about 28% (Table and Figure 12.1).
The amount spent on health care for people with CVD varies widely across the EU. Cost per 
capita varied almost 12 fold in 2006, from €34 in Romania to €413 in Germany. Percentage 
of total health care expenditure spent on CVD varied from 5% in Luxembourg, Denmark and 
Cyprus to 17% in Poland (Table 12.1).
Around one-fifth (22%) of health care expenditure on CVD in the EU is due to CHD (Tables 
12.1 and 12.2). CHD cost the health care systems of the EU just under €24 billion in 2006. 
Inpatient hospital care for people who have CHD accounted for about 52% of these costs and 
drugs accounted for about 25% (Table 12.2).
Almost one-fifth (17%) of health care expenditure on CVD in the EU is due to stroke (Tables 
12.1 and 12.3). Stroke cost the health care systems of the EU over €18 billion in 2006. Inpatient 
hospital care for people who have strokes accounted for about 80% of these costs and drugs 
accounted for about 6% (Table 12.3).
Non health-care costs
Looking only at the cost of CVD to the health care systems of the EU grossly underestimates the 
true cost of CVD. Production losses from death and illness in those of working age and from the 
informal care of people with the disease contribute greatly to the overall financial burden.
In 2006, production losses due to mortality and morbidity associated with CVD cost the EU 
almost €41 billion, with around two-thirds of this cost due to death (€26.9 billion) and one-third 
due to illness (€13.9 billion) in those of working age (Table 12.4).
Just under half (46%) of the production losses due to mortality from CVD and almost a third 
(31%) of the cost of production losses due to morbidity were due to CHD. In 2006, production 
losses due to mortality and morbidity associated with CHD cost the EU just under €17 billion 
(Table 12.4).





than one-quarter (26%) of the cost of production losses due to morbidity were due to stroke. In 
2006, production losses due to mortality and morbidity associated with stroke cost the EU over 
€8 billion (Table 12.4).
The cost of informal care for people with CVD in the EU is another important non-health care 
cost. In 2006, the total cost of providing this care was just under €42 billion. Just over one-fifth 
of these costs were due to CHD (€9.1 billion) and over one-quarter were due to stroke (€11.1 
billion) (Table 12.4).
Total costs
Overall CVD is estimated to cost the EU economy €192 billion a year. This represents a total 
annual cost per capita of €3914. Per capita costs vary over 11 fold between Member States - 
from around under €60/capita/year in Bulgaria to over €600/capita/year in Germany and the 
UK4. Of the total cost of CVD in the EU, around 57% is due to direct health care costs, 21% to 
productivity losses and 22% to the informal care of people with CVD (Table 12.5).
CHD is estimated to cost the EU economy over €49 billion a year: just over one-quarter of the 
overall cost of CVD. Of the total cost of CHD in the EU, around 48% is due to direct health 
care costs, 34% to productivity losses and 18% to the informal care of people with CHD (Table 
12.5).
Stroke is estimated to cost the EU economy over €38 billion a year: around one-fifth of the overall 
cost of CVD. Of the total cost of stroke in the EU, around 49% is due to direct health care costs, 
23% to productivity losses and 29% to the informal care of people with stroke (Table 12.5).
1. The figures for this section are from a new cost of illness study by researchers at the Health Economics Research Centre, Department 
of Public Health, University of Oxford. The analysis was carried out for the year 2006, and costs calculated for individual Member 
States and the EU as a whole. Details of the methods and data used can be found at www.heartstats.org/eucosts
2. Due to lack of data across the EU, this figure does not include the money spent on non-clinical activities concerned with the primary 
prevention of CVD, for example, public anti-smoking campaigns, nutrition education etc. However, the cost of drugs prescribed in 
primary care for both primary and secondary prevention are included.
3. The cost of informal care is equivalent to the opportunity costs of unpaid care. It is a measure of the amount of money that carers 
forgo to provide unpaid care for their spouse, friend or relative living with CVD. For more details of the methods used see www.
heartstats.org/eucosts.


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Member states of the WHO European Region
There are 53 member states of the WHO European region. These are listed below, with the 2006 
mid-year population estimates for males and females. The 27 countries of the European Union are 
identified with an asterisk. A map follows, with countries identified by their three letter code.
Country Code WHO mortality strata  Male population Female population
  sub-region 2006 2006
Albania ALB EUR-B 1,560,000 1,587,000
Andorra AND EUR-A 40,530 37,183
Armenia ARM EUR-B 1,400,000 1,608,000
Austria* AUT EUR-A 4,016,000 4,189,000
Azerbaijan AZE EUR-B 4,109,000 4,362,000
Belarus BLR EUR-C 4,529,000 5,171,000
Belgium* BEL EUR-A 5,122,000 5,315,000
Bosnia and Herzegovina BIH EUR-B 1,899,000 2,013,000
Bulgaria* BGR EUR-B 3,712,000 3,959,000
Croatia HRV EUR-A 2,193,000 2,363,000
Cyprus* CYP EUR-A 411,000 434,000
Czech Republic* CZE EUR-A 4,970,000 5,239,000
Denmark* DNK EUR-A 2,696,000 2,750,000
Estonia* EST EUR-C 609,000 716,000
Finland* FIN EUR-A 2,578,000 2,684,000
France* FRA EUR-A 29,578,000 31,145,000
Georgia GEO EUR-B 2,094,000 2,340,000
Germany* DEU EUR-A 40,408,000 42,308,000
Greece* GRC EUR-A 5,504,000 5,636,000
Hungary* HUN EUR-C 4,794,000 5,277,000
Iceland ISL EUR-A 149,000 149,000
Ireland* IRL EUR-A 2,095,000 2,115,000
Israel ISR EUR-A 3,389,000 3,458,000
Italy* ITA EUR-A 28,219,000 29,920,000
Kazakhstan KAZ EUR-C 7,290,852 7,856,177
Kyrgyzstan KYR EUR-B 2,622,000 2,703,000
Latvia* LVA EUR-C 1,050,000 1,246,000
Lithuania* LTU EUR-C 1,593,000 1,824,000
Luxembourg* LUX EUR-A 232,000 239,000
Macedonia, TFYR MKD EUR-B 1,016,000 1,021,000
Malta* MAL EUR-A 200,000 203,000
Moldova MDA EUR-C 2,006,000 2,189,000
Monaco MON EUR-A 16,000 16,000
Montenegro MTN EUR-B 306,839 316,439
Netherlands* NLD EUR-A 8,127,000 8,240,000
Norway NOR EUR-A 2,307,000 2,336,000
Poland* POL EUR-B 18,664,000 19,834,000
Portugal* PRT EUR-A 5,099,000 5,446,000
Romania* ROM EUR-B 10,536,000 11,093,000
Russian Federation RUS EUR-C 66,080,000 76,458,000
San Marino SMR EUR-A 13,000 14,000
Serbia SRB EUR-B 3,618,040 3,822,729
Slovakia* SVK EUR-B 2,619,000 2,782,000
Slovenia* SVN EUR-A 960,000 1,006,000
Spain* ESP EUR-A 21,304,000 22,075,000
Sweden* SWE EUR-A 4,503,000 4,567,000
Switzerland CHE EUR-A 3,516,000 3,748,000
Tajikistan TAJ EUR-B 3,267,000 3,324,000
Turkey TUR EUR-B 37,362,000 36,813,000
Turkmenistan TUK EUR-B 2,412,000 2,487,000
Ukraine UKR EUR-C 21,051,000 24,935,000
United Kingdom* GBR EUR-A 29,258,000 30,589,000
Uzbekistan UZB EUR-B 13,417,000 13,564,000
Notes: * Member state of the European Union
  EUR-A: Very low child and very low adult mortality
  EUR-B: Low child and low adult mortality
  EUR-C: Low child and high adult mortality
Source: WHO (2007) European Health For All database www.euro.who.int/hfadb. Accessed October 2007.
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